Yayınlar & Eserler

Yayın Ağı
Makaleler 251
Tümü (251)
SCI-E, SSCI, AHCI (167)
SCI-E, SSCI, AHCI, ESCI (186)
ESCI (15)
Scopus (186)
TRDizin (75)
Diğer Yayınlar (23)

1. Real-world outcomes and prognostic factors in primary mediastinal B-cell lymphoma: a multicenter study of 157 patients

Küçükyurt S., Koca O., TERZİ DEMİRSOY E., AKIN S., Doğan A., Gören D., et al.
Annals of Hematology , cilt.104, sa.9, ss.4679-4690, 2025 (SCI-Expanded, Scopus) identifier identifier identifier identifier

2. Evaluating the long-term efficacy of umbilical cord-derived mesenchymal stem cell therapy in retinitis pigmentosa: Findings from a 1-to-4-year follow-up

Oner A., KAHRAMAN N. S., ÜNAL A.
Stem Cells Translational Medicine , cilt.14, sa.8, 2025 (SCI-Expanded, Scopus) identifier identifier identifier identifier

3. The efficacy and safety of therapeutic thrombocytapheresis in patients with extreme thrombocytosis

Çelik S., Güven Z. T., KEKLİK M., ÜNAL A., KAYNAR L.
Transfusion Medicine , cilt.35, sa.3, ss.253-257, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

4. Familial hemophagocytic lymphohistiocytosis case in adult age

FİDAN K., ÇİLEK H. G., ÇELİK S., BAYDAR M., ÜNAL A., ÖZÇELİK F., et al.
Journal of Current Hematology & Oncology Research , cilt.3, sa.2, ss.42-45, 2025 (Hakemli Dergi) identifier

5. Hiperviskozitenin Aksine Hayatı Tehdit Eden Edinsel Koagülopati Vakası: Lenfoplazmasitik Lenfoma

YILDIRIM KARAHANCI M., MANDACI ŞANLI N., EMRE ÜNSAL Ş., FİDAN K., AKYOL G., KEKLİK M., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , cilt.9, sa.1, ss.1-4, 2025 (TRDizin) identifier identifier

6. Effective engraftment via granulocyte transfusion in pre-engraftment febrile neutropenia following allogeneic hematopoietic stem cell transplantation: granulocyte transfusion as bridge therapy

MANDACI ŞANLI N., ÜNAL A.
Therapeutic Advances in Hematology , cilt.16, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

7. Low-dose anti-thymocyte globulin combined with low-dose post-transplant cyclophosphamide: a novel approach to prevent graft-versus-host disease in haploidentical stem cell transplantation

MANDACI ŞANLI N., ÜNAL A.
THERAPEUTIC ADVANCES IN HEMATOLOGY , cilt.16, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

8. Frequency of Genetic Mutations in Patients With Chronic Lymphocytic Leukemia and Their Effects on Survival

GÖLBAŞI M., ÜNAL A., ÖZKUL Y., DÜNDAR M., Sanli N. M., AKYOL G., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , 2024 (SCI-Expanded, Scopus) identifier

9. Outcomes of allogeneic haematopoietic cell transplantation for myelofibrosis in children and adolescents: the retrospective study of the EBMT Paediatric Diseases WP

Wachowiak J., Galimard J., Dalissier A., Rihani R., Alsaedi H., Wynn R. F., et al.
BONE MARROW TRANSPLANTATION , cilt.59, sa.8, ss.1057-1069, 2024 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

10. Uric Acid Levels Might be A Prognostic Indicator For Survival in Patients Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation. Single-Center Experience

MANDACI ŞANLI N., KEKLİK M., ÜNAL A.
Cumhuriyet Tıp Dergisi (ELEKTRONİK) , cilt.46, sa.2, ss.121-128, 2024 (Hakemli Dergi) identifier

11. Determination of the therapeutic effects of apigenin on chronic myeloid leukemia stem cells; a mechanistic approach

Ünal A., Göktepe Ö., Çetinkaya M., Baran Y.
Journal of current Hematology&Oncology , cilt.2, sa.2, ss.24-27, 2024 (Hakemli Dergi)

12. Comparison of drug-drug interaction checking databases for interactions involving BCR-ABL tyrosine kinase inhibitors

GÜNAY A., DEMİRPOLAT E., AYCAN M. B., ÜNAL A.
ISTANBUL JOURNAL OF PHARMACY , cilt.54, sa.1, ss.32-39, 2024 (ESCI, TRDizin) identifier

13. Germline genetic variants in Turkish familial multiple myeloma/monoclonal gammopathy of undetermined significance cases

AKKUŞ E., TUNCALI T., Akin H. Y., Aydin Y., Besisik S. K., GÜRKAN E., et al.
BRITISH JOURNAL OF HAEMATOLOGY , cilt.204, sa.3, ss.931-938, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

14. Determination of the therapeutic effects of apigenin on chronic myeloid leukemia stem cells; a mechanistic approach

Ünal A.
SCIENCERISE. MEDICAL SCIENCE , cilt.2, sa.2, ss.24-27, 2024 (Hakemsiz Dergi) Creative Commons License

15. SUCCESSFUL TREATMENT WITH GRANULOCYTE TRANSFUSION AND EARLY NEUTROPHIL ENGRAFTMENT IN ALLOGENEIC TRANSPLANT PATIENTS WITH FEBRILE NEUTROPENIA; DOES GRANULOCYTE TRANSFUSION SHORTEN THE NEUTROPHIL ENGRAFTMENT TIME?

ÜNAL A., TUBAY Ş. E., KEKLİK M., Sanli N. M., AKYOL G.
BONE MARROW TRANSPLANTATION , cilt.58, sa.SUPP1, ss.382-383, 2023 (SCI-Expanded, Scopus) identifier

16. TWO CASES OF B-ALL IN MYELOMA PATIENTS RECEIVING LONG MAINTENANCE IMID THERAPY AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION

AKYOL G., BAYDAR M., FİDAN K., TAŞER KANAT N., Sanli N. M., KEKLİK M., et al.
BONE MARROW TRANSPLANTATION , cilt.58, sa.SUPP1, ss.494, 2023 (SCI-Expanded, Scopus) identifier

17. EFFICACY COMPARISON OF LEVOFLOXACIN AND RIFAXIMIN PROPHYLAXIS IN PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION

AKYOL G., Patat Y., ÜNAL A., KEKLİK M., KAYNAR L.
BONE MARROW TRANSPLANTATION , cilt.58, sa.SUPP1, ss.441-442, 2023 (SCI-Expanded, Scopus) identifier

18. MM-123 Determination of T Lymphocyte Subgroups in the Bone Marrow Microenvironment in Multiple Myeloma: Can Tumor-Directed T-Cells Play a Role in Fighting Cancer?

Ünal A., Dinç G., Celikzencir H., Mutlu N., Nayır R., Kutuk S., et al.
CLINICAL LYMPHOMA, MYELOMA AND LEUKEMIA , cilt.23, sa.Supplement 1, ss.474, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

19. Determination of T Lymphocyte Subgroups in the Bone Marrow Microenvironment in Multiple Myeloma: Can Tumor-Directed T-Cells Play a Role in Fighting Cancer?

ÜNAL A., DİNÇ G., Celikzencir H., Mutlu N., Nayir R., Kutuk S., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.23, ss.474, 2023 (SCI-Expanded, Scopus) identifier

20. The Tip of the Iceberg: Vaginal Bleeding and Granulocytic Sarcoma of the Uterus

Celik S., Guven Z. T., YILDIRIM T., KAYNAR L., ESER B., Cetin M., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.23, ss.273, 2023 (SCI-Expanded, Scopus) identifier

21. A Survey of Chronic Lymphocytic Leukemia Treatment Approaches in Turkey: A Turkish Hematology Network Group Study

GÜVENÇ B., ÖZCAN M. A., SÖNMEZ M., Turgut M., ÜNAL A.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.23, ss.324, 2023 (SCI-Expanded, Scopus) identifier

22. The Invisible Damage of the COVID-19 Pandemic to Our Apheresia Unit and the National Economy

AKYOL G., BAYDAR M., Baysal S., KEKLİK M., ÜNAL A.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.23, ss.475-476, 2023 (SCI-Expanded, Scopus) identifier

23. Acute Promyelocytic Leukemia and Stem Cell Transplantation: Case Series, Single Center Experience

ÜNAL A., FİDAN K., BAYDAR M., TAŞER KANAT N., Sanli N. M., KEKLİK M.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.23, ss.271, 2023 (SCI-Expanded, Scopus) identifier

24. Clofarabine, cyclophosphamide, and etoposide (CLOVE) in adult patients with relapsed/refractory acute T-cell lymphoblastic leukemia: single-center experience

Guven Z. T., Tubay Ş. E., Celik S., Keklik M., Ünal A.
CUKUROVA MEDICAL JOURNAL , cilt.48, sa.2, ss.535-540, 2023 (ESCI, TRDizin) Creative Commons License identifier identifier

25. Coronavirus Anxiety Level and COVID-19 Vaccine Attitude Among Patients With Hematological Malignancies

Güven Z. T., Çelik S., Keklik M., Ünal A.
CUREUS , cilt.15, sa.5, ss.1-9, 2023 (ESCI) Sürdürülebilir Kalkınma

26. Simultaneous Evaluation of Serum Immunofixation Electrophoresis and Serum Free Light Chain Measurements Used in the Diagnosis of Monoclonal Gammopathy and Smoldering Multiple Myeloma of Uncertain Significance in the Presence of Risk Factors

öner i., SAÇKAN F., ÜNAL A.
ACTA ONCOLOGICA TURCICA , cilt.56, sa.1, ss.33-45, 2023 (TRDizin) Creative Commons License identifier

27. Does HLA tissue group change after granulocyte transfusion?

Unal A., Baydar M., KÖKER M. Y., Keklik M., Fidan K., Guven Z. T., et al.
BONE MARROW TRANSPLANTATION , cilt.57, sa.SUPPL 1, ss.416, 2022 (SCI-Expanded, Scopus) identifier

28. COVID-19 in hematopoietic stem-cell transplantation recipients: Single center experience

Guven Z. T., Celik S., Keklik M., Unal A.
BONE MARROW TRANSPLANTATION , cilt.57, sa.SUPPL 1, ss.290-291, 2022 (SCI-Expanded, Scopus) identifier

29. Secondary hypogammaglobulinemia in cll

Unal A., Fidan K., Keklik M., Celik S., Baydar M., Sanli N. M., et al.
BONE MARROW TRANSPLANTATION , cilt.57, sa.SUPPL 1, ss.306-307, 2022 (SCI-Expanded, Scopus) identifier

30. Long-term follow-up of ruxolitinib for therapy in corticosteroid refractory chronic graft-versus-host disease: A single center-experience

Sanli N. M., Karakus E., Keklik M., Unal A.
BONE MARROW TRANSPLANTATION , cilt.57, sa.SUPPL 1, ss.205, 2022 (SCI-Expanded, Scopus) identifier

31. Granulocyte transfusion in patients with mucositis after allogeneic hematopoietic stem cell transplantation

Yildizhan E., Varol F., Ciftci S., Tubay E., Unal A.
BONE MARROW TRANSPLANTATION , cilt.57, sa.SUPPL 1, ss.160-161, 2022 (SCI-Expanded, Scopus) identifier

32. Long-term outcome in patients receiving imatinib for steroid-refractory chronic GVHD/ for refractory chronic graft-versushost disease with fibrotic features: A single-center experience

Sanli N. M., Karakus E., Unal A., Keklik M.
BONE MARROW TRANSPLANTATION , cilt.57, sa.SUPPL 1, ss.212-213, 2022 (SCI-Expanded, Scopus) identifier

33. Design of the VIALE-M phase III trial of venetoclax and oral azacitidine maintenance therapy in acute myeloid leukemia

Ivanov V., Yeh S., Mayer J., Saini L., ÜNAL A., Boyiadzis M., et al.
FUTURE ONCOLOGY , cilt.18, sa.26, ss.2879-2889, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

34. Secondary Hypogammaglobulinemia in Patients with Chronic Lymphocytic Leukemia Receiving Ibrutinib Therapy

ÇELİK S., KAYNAR L., GÜVEN Z. T., BAYDAR M., KEKLİK M., ÇETİN M., et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , cilt.38, sa.2, ss.282-289, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

35. İnvaziv Duktal Meme Karsinomu Tedavisi Sonrası Gelişen Akut Myeloid Lösemi

Güven Z. T., Çelik S., Keklik M., Ünal A., Kaynar L.
Türkiye’de Lösemi Lenfoma Miyelom Araştırmaları (LLM) dergisi , cilt.5, sa.3, ss.66-69, 2022 (TRDizin)

36. Impact of K-ras Mutation and C-myc Overexpression on the Prognosis of Diffuse Large B-Cell Lymphomas

Ertas S. K., ÜNAL A., Akalin H., BARAN M., CANÖZ Ö., KONTAŞ O., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.32, sa.1, ss.16-22, 2022 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier

37. Prophylactic Central Nervous System Irradiation Is Not Indispensable in Adult Patients with Acute Lymphoblastic Leukemia: A Multicenter Retrospective Cohort Study

ÇINAR O. E., GÖKER H., FİDAN K., Aydin O., Pashayev T., MALKAN Ü. Y., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.39, sa.3, ss.152-159, 2022 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier identifier

38. Immunoglobulin V(D) J Recombination, Protein Ubiquitination, Cell Adhesion and Sonic Hedgehog Gene Variants are detected among familial Multiple Myeloma subjects following whole exome sequencing

AKKUŞ E., TUNCALI T., Aydin Y., Besisik S. K., GÜRKAN E., Ratip S., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.21, 2021 (SCI-Expanded, Scopus) identifier

39. Nakil Öncesi Yüksek Serum D-dimer Düzeyi Allojenik Hematopoietik Kök Hücre Nakli Yapılan Hastalarda Sağkalımı Belirlemede Prognostik Bir Belirteç Olabilir

ŞANLI N. M., EMEKLİOĞLU M., KEKLİK M., ÜNAL A.
LLM dergi , cilt.2, sa.2, ss.44-51, 2021 (TRDizin) Creative Commons License identifier

40. The follow up of hepatic serology, hepatic reactivation and lifespan of multiple myeloma transplant patients

AKYOL G., ÜNAL A.
EUROPEAN JOURNAL OF IMMUNOLOGY , cilt.51, ss.343, 2021 (SCI-Expanded, Scopus) identifier

41. A case of primary hemophagocytic syndrome seen in adult age

FİDAN K., KEKLİK M., Sanli N. M., AKYOL G., BAYDAR M., ÇELİK S., et al.
EUROPEAN JOURNAL OF IMMUNOLOGY , cilt.51, ss.337, 2021 (SCI-Expanded, Scopus) identifier

42. Immune trombocytic purpura during the course of COVID-19 disease:three cases report

FİDAN K., ÜNAL A., KEKLİK M., AKYOL G., BAYDAR M., ÇELİK S., et al.
EUROPEAN JOURNAL OF IMMUNOLOGY , cilt.51, ss.329, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

43. Clinical characteristics and therapeutic outcomes of paroxysmal nocturnal hemoglobinuria patients in Turkey: a multicenter experience

Goren Sahin D., Akay O. M., KEKLİK M., Okan V., KARAKUŞ A., Demir C., et al.
ANNALS OF HEMATOLOGY , cilt.100, sa.7, ss.1667-1675, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

44. Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial

Dimopoulos M. A., Terpos E., Boccadoro M., Delimpasi S., BEKSAÇ M., Katodritou E., et al.
LANCET ONCOLOGY , cilt.22, sa.6, ss.801-812, 2021 (SCI-Expanded, Scopus) identifier identifier identifier identifier

45. Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMT

Gilleece M. H., Shimoni A., Labopin M., Robinson S., Beelen D., Socie G., et al.
BLOOD CANCER JOURNAL , cilt.11, sa.5, 2021 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

46. Hematopoetik Kök Hücre Nakli Sırasında Gelişen Epileptik Nöbetlerin Değerlendirilmesi: Tek Merkez Deneyimi

ÇELİK S., GÜVEN Z. T., KEKLİK M., KAYNAR L., ESER B., ÇETİN M., et al.
Acta Oncologica Turcica , cilt.51, sa.1, ss.40-50, 2021 (TRDizin) identifier

47. Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data

TOMBAK A., Tanrikulu F. P., Durusoy S. S., DİNÇYÜREK H. D., KAYA E., Umit E. G., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.38, sa.4, ss.273-285, 2021 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier identifier

48. Hematopoietic Stem Cell Transplantation for Patients with Paroxysmal Nocturnal Hemoglobinuria with or without Aplastic Anemia: A Multicenter Turkish Experience

Yilmaz F., SOYER N., Seval G. C., Bozdag S. C., TOPÇUOĞLU P., ÜNAL A., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.38, sa.3, ss.195-203, 2021 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier identifier

49. Evolution of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in turkey: a multicenter retrospective analysis

KEKLİK KARADAĞ F., Yenerel M. N., YILMAZ M., ÜSKÜDAR TEKE H., ÖZKOCAMAN V., Tuglular T. F., et al.
AMERICAN JOURNAL OF BLOOD RESEARCH , cilt.11, sa.3, ss.279-285, 2021 (ESCI) identifier

50. Allogeneic Hematopoietic Stem Cell Transplantation for BCR/ABL1-Negative Myeloproliferative Neoplasms in Children - Retrospective Report on Behalf of I-BFM SCT Committee and EBMT Pediatric Diseases WP

Wachowiak J., Galimard J., Dalissier A., Tbakhi A., Al-Seraihy A., Diaz M. A., et al.
BONE MARROW TRANSPLANTATION , cilt.55, sa.SUPPL 1, ss.155-156, 2020 (SCI-Expanded, Scopus) identifier

51. Low-dose cyclophosphamide and granulocyte colony-stimulating factor are sufficient for peripheral blood stem cell mobilization in patients with multiple myeloma

Keklik M., Karakus E., Kaynar L., Akyol G., Guven Z., Celik S., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.59, sa.5, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

52. A Comparison of the BEAM and MITO/MEL Conditioning Regimens for Autologous Hematopoietic Stem Cell Transplantation in Hodgkin Lymphoma: An Analysis of Efficiency and Treatment-Related Toxicity

Yeral M., Aytan P., Gungor B., Boga C., ÜNAL A., Koc Y., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.20, sa.10, ss.652-660, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

53. Incidence and risk factors for hepatic sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: A retrospective multicenter study of Turkish hematology research and education group (ThREG)

SOYER N., Gunduz M., Tekgunduz E., Deveci B., Ozdogu H., ŞAHİN H. H., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.59, sa.4, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

54. Assessment of Post-transplantation Liver Function Tests in Patients Undergoing Allogeneic Stem Cell Transplantation

Kiziltepe M., Yildizhan E., ÜNAL A., ÇETİN M., Eser B., KAYNAR L.
ERCIYES MEDICAL JOURNAL , cilt.42, sa.1, ss.60-65, 2020 (ESCI, TRDizin) identifier identifier

55. Study for the Diagnostic Screening of Paroxysmal Nocturnal Hemoglobinuria in Older Patients with Unexplained Anemia and/or Cytopenia

Ozdemir Z. N., İLHAN O., Ozet G., Falay M., Yenerel M., Tuglular T., et al.
CLINICAL LABORATORY , cilt.66, sa.9, ss.1709-1715, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

56. A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcome

BEKSAÇ M., Seval G. C., Kanellias N., Coriu D., Rosinol L., Ozet G., et al.
HAEMATOLOGICA , cilt.105, sa.1, ss.201-208, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

57. Patterns of Hydroxyurea Prescription and Use in Routine Clinical Management of Polycythemia Vera: A Multicenter Chart Review Study

BÜYÜKAŞIK Y., ALİ R., Turgut M., SAYDAM G., Yavuz S., ÜNAL A., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.37, sa.3, ss.177-185, 2020 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier

58. Genetic Characteristics, Infectious, and Noninfectious Manifestations of 32 Patients with Chronic Granulomatous Disease.

Aygun D., Koker M. Y., Nepesov S., Koker N., Van L., De B., et al.
International archives of allergy and immunology , cilt.181, ss.540-550, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

59. A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience

Cekdemir D., Guvenc S., Ozdemirkiran F., Eser A., Topts T., ÖZKOCAMAN V., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.36, sa.4, ss.230-237, 2019 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier

60. Sclerosing Extramedullary Hematopoietic Tumor

DENİZ K., KAHRİMAN G., KOÇYİĞİT I., Okten T., ÜNAL A.
TURKISH JOURNAL OF HEMATOLOGY , cilt.35, sa.3, ss.209-210, 2018 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier

61. Allojenik Kök Hücre Nakli Sonrası Nötropenik Dönem Takibinde Granülosit İnfüzyonunun Yeri

KENİ N., ÜNAL A., KAYNAR L., ESER B., birekul a., GÜVEN Z. T., et al.
Türkiye’de Lösemi Lenfoma Miyelom Araştırmaları Dergisi(LLM Dergi) , cilt.2, ss.42-46, 2018 (Hakemli Dergi) Creative Commons License

62. Rituximab plus bendamustine or chlorambucil for chronic lymphocytic leukemia: primary analysis of the randomized, open-label MABLE study

Michallet A., Aktan M., Hiddemann W., Ilhan O., Johansson P., Laribi K., et al.
HAEMATOLOGICA , cilt.103, sa.4, ss.698-706, 2018 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

63. ASSESSMENT OF FACTORS AFFECTING ENGRAFTMENT AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION

DOĞRUEL F., OZTURK C. P., ALBAYRAK M., KAYNAR L., Sivgin S., ESER B., et al.
JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE , cilt.8, sa.4, ss.332-335, 2017 (ESCI) Creative Commons License identifier

64. Miyelodisplastik Sendromun Hipometile Edici Ajanlarla Tedavisi Gerçek Hayat Verileri, Tek Merkez Deneyimi

KENİ N., UYSAL E., YILDIZHAN E., ERMİŞ TURAK E., KAYNAR L., ESER B., et al.
LLM Dergi , cilt.1, ss.49-54, 2017 (Hakemli Dergi) Creative Commons License

65. Transplantation of Single MismatchHematopoietic Stem Cells with Third Party Mesenchymal Stem Cells for Severe Aplastic Anemia: A Case Reportand Mini Review

KENİ N., KAYNAR L., ÜNAL A., DEMİR K., ERMİŞ TURAK E., GÖNEN Z. B., et al.
Annals of Hematology Oncology , cilt.4, ss.1150, 2017 (Hakemli Dergi)

66. Additional infusions of mesenchymal stem cells improve response rate in multidrug-resistant GvHD patients

ÇETİN M., AKYOL G., GÖNEN Z. B., KEKLIK M., ZARARSIZ G., ÜNAL A., et al.
BONE MARROW TRANSPLANTATION , cilt.52, sa.5, ss.783-785, 2017 (SCI-Expanded, Scopus) Creative Commons License identifier

67. Multicenter Retrospective Analysis of Turkish Patients with Chronic Myeloproliferative Neoplasms

SOYER N., HAZNEDAROĞLU İ. C., Comert M., ÇEKDEMİR D., Yilmaz M., ÜNAL A., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.34, sa.1, ss.27-33, 2017 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier

68. TcR alpha beta-depleted haploidentical transplantation results in adult acute leukemia patients

Kaynar L., Demir K., Turak E. E., OZTURK C. P., ZARARSIZ G., GÖNEN Z. B., et al.
HEMATOLOGY , cilt.22, sa.3, ss.136-144, 2017 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

69. SUCCESSFUL TREATMENT WITH GRANULOCYTE TRANSFUSION AND EARLY NEUTROPHIL ENGRAFTMENT IN ALLOGENEIC TRANSPLANT PATIENTS WITH FEBRILE NEUTROPENIA

ÜNAL A., KAYNAR L., KENİ N., ERMİŞ TURAK E., ŞIVGIN S., ESER B., et al.
Haematologica-The Hematology Journal , cilt.102, ss.622-623, 2017 (SCI-Expanded, Scopus)

70. URIC ACID LEVEL MIGHT BE A PROGNOSTIC INDICATOR FOR SURVIVAL IN PATIENTS WHO UNDERWENT ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION. SINGLE CENTER EXPERIENCE

Mandacı Şanlı N., Şıvgın S., Kaynar L., Eser B., Çetin M., Ünal A.
Haematologica-The Hematology Journal , cilt.102, ss.859, 2017 (SCI-Expanded, Scopus)

71. Does Renal Tubular Injury-Induced Local Tissue Hypoxia Involve Post-Transplantation Erythrocytosis?

ÜNAL A.
Transplantation Proceedings , cilt.49, ss.1930-1934, 2017 (SCI-Expanded, Scopus) identifier identifier identifier

72. Dendritic Cell Production from Allogeneic Donor Cd34+ Stem Cells and Mononuclear Cells; Cancer Vaccine Ali Unal, Ayse Birekul, Mehmet Cagri Unal, Esen Karakus, Yavuz Köker, Yusuf Ozkul ve Faruk Metin Comu

ÜNAL A., BİREKUL A., ÜNAL M. Ç., KÖKER M. Y., ÖZKUL Y., KARAKUŞ E., et al.
BLOOD , cilt.128, sa.225723, ss.5723, 2016 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

73. Increased Bone Marrow Iron Scores Are Strongly Correlated With Elevated Serum Ferritin Levels and Poorer Survival in Patients With Iron Overload That Underwent Allogeneic Hematopoietic Stem Cell Transplantation: A Single Center Experience

Sivgin S., Nazlim S., ZARARSIZ G., Baspinar O., KAYNAR L., DENİZ K., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.16, sa.10, ss.582-587, 2016 (SCI-Expanded, Scopus) identifier

74. TcR?ß-depleted haploidentical transplantation results in adult acute leukemia patients.

KAYNAR L., DEMIR K., ERMİŞ TURAK E., ÖZTÜRK Ç., ZARARSIZ G., GÖNEN Z. B., et al.
HEMATOLOGY , ss.1-9, 2016 (SCI-Expanded, Scopus)

75. 5 year Experience of Oral Deferasirox Exjade Use Prior to Transplantation in Patients with Iron Overload that Underwent Allogeneic Hematopoietic Stem Cell Transplantation alloHSCT Retrospective Analysis of a Single Center from Turkey

ŞIVGIN S., YILDIZHAN E., ÜNAL A., KAYNAR L., ZARARSIZ G., ESER B., et al.
Clinical Lymphoma Myeloma & Leukemia , cilt.16, ss.34, 2016 (SCI-Expanded, Scopus)

76. Serum Ferritin Levels Prior to Transplantation Might be Used for Predicting the Severity of Transfusional Iron Overload in Allogeneic Hematopoietic Stem Cell Transplantation alloHSCT Recipients

ŞIVGIN S., YILDIZHAN E., ZARARSIZ G., ESER B., ÇETİN M., ÜNAL A., et al.
Clinical Lymphoma Myeloma & Leukemia , cilt.16, ss.28-29, 2016 (SCI-Expanded, Scopus)

77. Cytogenetic Features of Elderly Turkish Myelodysplastic Syndrome Patients

Keklik M., Buyukoglan R., Sivgin S., ESER B., KAYNAR L., ÇETİN M., et al.
ERCIYES MEDICAL JOURNAL , cilt.38, sa.3, ss.95-98, 2016 (ESCI, TRDizin) Creative Commons License identifier

78. Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma

Palumbo A., Chanan-Khan A., Weisel K., Nooka A. K., MASSZI T., Beksac M., et al.
NEW ENGLAND JOURNAL OF MEDICINE , cilt.375, sa.8, ss.754-766, 2016 (SCI-Expanded, Scopus) identifier identifier identifier

79. The Prognostic Significance of Elevated Serum Ferritin Levels Prior to Transplantation in Patients With Lymphoma Who Underwent Autologous Hematopoietic Stem Cell Transplantation (autoHSCT): Role of Iron Overload

Sivgin S., Karamustafaoglu M. F., Yildizhan E., ZARARSIZ G., KAYNAR L., ESER B., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.16, 2016 (SCI-Expanded, Scopus) identifier

80. Increased Hepatic Iron Content Predicts Poor Survival in Patients With Iron Overload Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation

Sivgin S., Baldane S., DENİZ K., ZARARSIZ G., KAYNAR L., ÇETİN M., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.16, 2016 (SCI-Expanded, Scopus) identifier

81. Evaluation of the efficacy and safety of original filgrastim (Neupogen (R)), biosimilar filgrastim (Leucostim (R)) and Lenograstim (Granocyte (R)) in CD34(+) peripheral hematopoietic stem cell mobilization procedures for allogeneic hematopoietic stem cell transplant donors

Sivgin S., Karakuş E., Keklik M., ZARARSIZ G., Solmaz M., Kaynar L., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.54, sa.3, ss.410-415, 2016 (SCI-Expanded, Scopus) identifier

82. HLA A B AND DRB1 ALLELE FREQUENCIES IN ALLOGENEIC AND HAPLOIDENTICAL HEMATOPOIETIC STEM CELL

ÜNAL A., KAYNAR L., ÇETİN M., AKAR H. H. A., PATIROĞLU T.
HLA , cilt.87, ss.263, 2016 (SCI-Expanded, Scopus)

83. HLA- A, -B AND-DRB1 ALLELE FREQUENCIES IN ALLOGENEIC AND HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION AND THEIR RELATIONSHIPS TO MORTALITY

PATIROĞLU T., Akar H. H., ÇETİN M., KAYNAR L., ÜNAL A.
HLA , cilt.87, sa.4, ss.263, 2016 (SCI-Expanded, Scopus) identifier

84. A Flow Cytometric Scoring System in the Diagnosis of Mantle Cell Lymphoma

Keklik M., KÖKER M. Y., KORKMAZ S., Sivgin S., KAYNAR L., Camlica D., et al.
ERCIYES MEDICAL JOURNAL , cilt.38, sa.1, ss.25-28, 2016 (ESCI, Scopus, TRDizin) Creative Commons License identifier identifier

85. Immune recovery after transplantation of TCR?ß depleted allografts from haploidentical donors in adult patients

KAYNAR L., Demir K., Pala Ç., ZARARSIZ G., GÖNEN Z. B., ŞIVGIN S., et al.
BONE MARROW TRANSPLANTATION , cilt.51, ss.159, 2016 (SCI-Expanded, Scopus)

86. Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplantation Solid Tumors Working Party

Necchi A., Miceli R., Bregni M., BOKEMEYER C., Berger L. A., Oechsle K., et al.
BONE MARROW TRANSPLANTATION , cilt.51, sa.3, ss.384-390, 2016 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

87. Association of Macroeconomic Factors With Nonrelapse Mortality After Allogeneic Hematopoietic Cell Transplantation for Adults With Acute Lymphoblastic Leukemia: An Analysis From the Acute Leukemia Working Party of the EBMT

Giebel S., Labopin M., Ibatici A., Browne P., Czerw T., Socie G., et al.
ONCOLOGIST , cilt.21, sa.3, ss.377-383, 2016 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

88. Factors affecting survival in acute leukemia with donor lymphocyte infusion in the first relapse after allogeneic stem cell transplantation

Kurnaz F., Sahin C., KAYNAR L., PALA C., Sivgin S., Altuntas F., et al.
JOURNAL OF BUON , cilt.21, sa.1, ss.227-234, 2016 (SCI-Expanded, Scopus) identifier

89. DAPSONE INDUCED APLASTIC ANEMIA

ÜSKÜDAR TEKE H., TOKMAK S., UĞUR H., ÜNAL A., KARAKÜKÇÜ Ç.
OSMANGAZİ JOURNAL OF MEDICINE , cilt.38, 2016 (SCI-Expanded)

90. Idelalisib at the Crossroads of B-Cell Lymphoproliferative Disorders

AKSU S., Ayyildiz O., Etgul S., GÖKER H., Gunes G., HAZNEDAROĞLU İ. C., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.26, sa.1, ss.12-19, 2016 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier

91. Pesg PNH diagnosis, follow-up and treatment guidelines

ŞAHİN F., Akay O. M., Ayer M., Dal M. S., Ertop S., İLHAN O., et al.
AMERICAN JOURNAL OF BLOOD RESEARCH , cilt.6, sa.2, ss.19-27, 2016 (ESCI) identifier

92. The prognostic significance of elevated serum ferritin levels prior to transplantation in patients with lymphoma that underwent autologous hematopoietic stem cell transplantation autoHSCT Role of iron overload

ŞIVGIN S., Mehmet Fatih K., YILDIZHAN E., ZARARSIZ G., KAYNAR L., ESER B., et al.
Clinical Lymphoma Myeloma & Leukemia , cilt.15, ss.71, 2015 (SCI-Expanded, Scopus)

93. Prognostic Significance of P53, Bcl-2, and Fas Expression in Patients with Primary Gastrointestinal Diffuse Large B-Cell Lymphoma

Cakmak E., Sari I., CANÖZ Ö., ESER B., Altuntas F., ÇETİN M., et al.
ERCIYES MEDICAL JOURNAL , cilt.37, sa.3, ss.102-105, 2015 (ESCI, Scopus, TRDizin) identifier identifier

94. Hepatic iron overload HIO is strongly correlated with serum ferritin levels and inferior survival in patients that underwent allogeneic hematopoietic stem cell transplantation alloHSCT

ŞIVGIN S., BALDANE S., DENİZ K., Zararsiz G., KAYNAR L., ÇETİN M., et al.
Clinical Lymphoma Myeloma & Leukemia , cilt.15, ss.3-4, 2015 (SCI-Expanded, Scopus)

95. Bone marrow iron store BMIS as a predictive marker for survival in patients with iron overload that underwent allogeneic hematopoietic stem cell transplantation alloHSCT

ŞIVGIN S., NAZLIM S., BALDANE S., KEKLİK M., ZARARSIZ G., KAYNAR L., et al.
Clinical Lymphoma Myeloma & Leukemia , cilt.15, ss.77-78, 2015 (SCI-Expanded, Scopus) identifier

96. Stem cell mobilization and collection from patients and healthy donors

Unal A.
TRANSFUSION AND APHERESIS SCIENCE , cilt.53, sa.1, ss.1-2, 2015 (SCI-Expanded, Scopus) identifier identifier identifier

97. FACTORS AFFECTING SURVIVAL IN PATIENTS WITH ACUTE LEUKEMIA WHO RECEIVED DONOR LYMPHOCYTE INFUSION IN THE TREATMENT OF FIRST RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

KURNAZ F., KAYNAR L., ESER B., ALTUNTAŞ F., ŞIVGIN S., pala ç., et al.
Haematologica-The Hematology Journal , cilt.100, ss.606, 2015 (SCI-Expanded, Scopus) identifier

98. Comparison of plateletpheresis on the Fenwal Amicus, Fresenius COM.TEC, and Trima Accel Cell separators

Keklik M., ESER B., KAYNAR L., Sivgin S., Keklik E., Solmaz M., et al.
JOURNAL OF CLINICAL APHERESIS , cilt.30, sa.3, ss.171-175, 2015 (SCI-Expanded, Scopus) identifier identifier identifier

99. Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis

BACIGALUPO A., SOCIE G., HAMLADJI R. M., ALJURF M., MASCHAN A., KYRCZ-KRZEMIEN S., et al.
HAEMATOLOGICA , cilt.100, sa.5, ss.696-702, 2015 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

100. Bone marrow iron stores BMIS might be used as a predictive marker for survival in patients with iron overload that underwent allogeneic hematopoietic stem cell transplantation alloHSCT

ŞIVGIN S., su n., muzaffer k., YILDIZHAN E., ZARARSIZ G., musa s., et al.
Bone Marrow Transplantation , cilt.50, ss.432, 2015 (SCI-Expanded, Scopus) Creative Commons License identifier

101. Contribution of Involved-field Radiotherapy to Survival in Patients With Relapsed or Refractory Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation

Eroglu C., KAYNAR L., ORHAN O., Keklik M., Sahin C., YILDIZ O., et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , cilt.38, sa.1, ss.68-73, 2015 (SCI-Expanded, Scopus) identifier identifier identifier

102. Comparison of double dose plateletpheresis on the Fenwal Amicus, Fresenius COM.TEC and Trima Accel cell separators

Keklik M., ESER B., KAYNAR L., Solmaz M., ÖZTÜRK A., Yay M., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.51, sa.2, ss.193-196, 2014 (SCI-Expanded, Scopus) identifier identifier identifier

103. The Coincidence of Familial Mediterranean Fever and Hypereosinophilia in a Patient with Hereditary Elliptocytosis

Keklik M., Unal A., Sivgin S., KONTAŞ O., EROĞLU E., YILMAZ S., et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , cilt.30, 2014 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

104. Detection of Acute Lymphoblastic Leukemia Involvement in Pleural Fluid in an Adult Patient with Ataxia Telangiectasia by Flow Cytometry Method

Keklik M., KÖKER M. Y., Sivgin S., Camlica D., Pala C., ÇETİN M., et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , cilt.30, 2014 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

105. Diarrhea in peripheral stem cell transplant recipients: a developing country's experience

Pala C., KAYNAR L., Buyukoglan R., Kurnaz F., Metan G., Yazar S., et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES , cilt.8, sa.5, ss.635-641, 2014 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

106. ALPHA BETA T CELL DEPLETION OF HLA IDENTICAL SIBLING STEM CELL TRANSPLANTATION TWO CENTER EXPERIENCE

KAYNAR L., uzay a., AKYOL G., pala ç., RATİP S., ŞIVGIN S., et al.
Bone Marrow Transplantation , cilt.49, ss.201, 2014 (SCI-Expanded, Scopus) identifier

107. ALPHA BETA T CELL DEPLETED HLA HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION SINGLE CENTER EXPERIENCE

pınarbaşı m., ÜNAL A., ÇETİN M., ESER B., KAYNAR L., KÖKER M. Y.
Bone Marrow Transplantation , cilt.49, ss.546, 2014 (SCI-Expanded, Scopus) Creative Commons License identifier

108. A rare but severe complication of filgrastim in a healthy donor: Splenic rupture

AKYOL G., Pala C., Yildirim A., Keklika M., Demir K., Dortdudak S., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.50, sa.1, ss.53-55, 2014 (SCI-Expanded, Scopus) identifier identifier identifier

109. Ibrutinib: From Molecule to Medicine

Ayyildiz O., Demirkan F., GÖKER H., Haznedaroglu I. C., Ilhan O., KAYNAR L., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.24, sa.3, ss.4-14, 2014 (SCI-Expanded, Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma identifier

110. The Coincidence of Familial Mediterranean Fever and Hypereosinophilia in a Patient with Hereditary Elliptocytosis

ÜNAL A., ŞIVGIN S., KAYNAR L., ESER B., ÇETİN M.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , cilt.30, ss.138-141, 2014 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

111. Comparison of total body irradiation plus cyclophosphamide with busulfan plus cyclophosphamide as conditioning regimens in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplant.

Eroglu C., Pala C., KAYNAR L., YARAY K., AKSÖZEN M. T., Bankir M., et al.
Leukemia & lymphoma , cilt.54, sa.11, ss.2474-9, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

112. The effect of volume replacement during therapeutic leukapheresis on white blood cell reduction in patients with extreme leukocytosis

Kurnaz F., Sivgin S., Pala C., yildirim R., Baldane S., Kaynar L., et al.
TRANSFUSION , cilt.53, sa.11, ss.2629-2634, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

113. The oral iron chelator deferasirox might improve survival in allogeneic hematopoietic cell transplant (alloHSCT) recipients with transfusional iron overload

Sivgin S., Baldane S., AKYOL G., Keklik M., KAYNAR L., Kurnaz F., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.49, sa.2, ss.295-301, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

114. Can low-dose preemptive valganciclovir replace standard intravenous ganciclovir treatment in recipients of allogeneic stem cell transplantation?

Kaynar L., Metan G., GÖKAHMETOĞLU S., Kurnaz F., Mumcuoglu H., ÖZTÜRK A., et al.
JOURNAL OF CHEMOTHERAPY , cilt.25, sa.5, ss.286-291, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

115. Allogeneic Hematopoietic Stem-Cell Transplantation for Acute Myeloid Leukemia in Remission: Comparison of Intravenous Busulfan Plus Cyclophosphamide (Cy) Versus Total-Body Irradiation Plus Cy As Conditioning Regimen-A Report From the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

NAGLER A., Rocha V., LABOPIN M., ÜNAL A., BEN OTHMAN T., CAMPOS A., et al.
JOURNAL OF CLINICAL ONCOLOGY , cilt.31, sa.28, ss.3549-3559, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

116. A case with Niemann-Pick disease and concomitant Kartagener's Syndrome Kartagener sendromu'nun eşlik ettiǧi bir Niemann-Pick olgusu

KEKLİK M., Şivgin S., Baldane S., Yildirim A., KONTAŞ O., KARDAŞ F., et al.
Erciyes Tip Dergisi , cilt.35, sa.3, ss.174-176, 2013 (Scopus, TRDizin) identifier

117. The Side Effects of Imatinib

Uzer E., ÜNAL A., KÖKER M. Y., Dogan S. A.
TURKISH JOURNAL OF HEMATOLOGY , cilt.30, sa.3, ss.341, 2013 (SCI-Expanded, Scopus, TRDizin) identifier

118. An acute transverse myelitis attack after total body irradiation: a rare case

KEKLİK M., KAYNAR L., YILDIRIM A., ŞIVGIN S., EROĞLU C., PALA Ç., et al.
case report , cilt.2013, ss.1-4, 2013 (Hakemli Dergi) identifier

119. FREQUENCY OF CHRONIC GRAFT VERSUS HOST DISEASE AND THE FACTORS FOR DEVELOPMENT OF CHRONIC GRAFT VERSUS HOST DISEASE

Uzer E., Oner I., Serin A., ZARARSIZ G., ÜNAL A., ÇETİN M.
HAEMATOLOGICA , cilt.98, ss.666, 2013 (SCI-Expanded, Scopus) identifier

120. THE PREVALENCE OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) AND ASYMPTOMATIC MULTIPLE MYELOMA (AMM) FOR HIGH RISK GROUPS

Oner I., ÜNAL A., PALA Ç., Sivgin S., Keklik M., PATIROĞLU T., et al.
HAEMATOLOGICA , cilt.98, ss.613, 2013 (SCI-Expanded, Scopus) identifier

121. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: A retrospective multicenter study

Korkmaz S., Keklik M., Sivgin S., YILDIRIM R., Tombak A., Kaya M. E., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.48, sa.3, ss.353-358, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

122. the turkish society of apheresis

ÜNAL A.
worldapheresis , sa.8, ss.3, 2013 (Hakemli Dergi)

123. Encephalitozoon intestinalis: A Rare Cause of Diarrhea in an Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Recipient Complicated by Albendazole-Related Hepatotoxicity

Sivgin S., ESER B., KAYNAR L., KURNAZ F., ŞIVGIN H., Yazar S., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.30, sa.2, ss.204-208, 2013 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma identifier identifier identifier

124. The comparison of Filgrastim (Neupogen (R)), biosimilar filgrastim (Leucostim (R)) and Lenograstim (Granocyte (R)) as a first line peripheral blood stem cell mobilization strategy in autologous hematopoieitic stem cell transplantation: A single center experience from Turkey

Sivgin S., Karakus E., KAYNAR L., Kurnaz F., Pala C., Keklik M., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.48, sa.3, ss.315-320, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

125. Therapeutic plasma exchange in patients with neurological diseases: Multicenter retrospective analysis

KAYA E., Keklik M., Sencan M., Yilmaz M., Keskin A., KİKİ İ., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.48, sa.3, ss.349-352, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

126. The results of therapeutic plasma exchange in patients with severe hyperthyroidism: a retrospective multicenter study.

Keklik M., Kaynar L., Yilmaz M., Sivgin S., Solmaz M., Pala C., et al.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis , cilt.48, sa.3, ss.327-30, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

127. Treatment with plasma exchange may serve benefical effect in patients with severe hyperbilirubinemia: A single center experience

Keklik M., Sivgin S., KAYNAR L., Pala C., Solmaz M., ÇETİN M., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.48, sa.3, ss.323-326, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

128. The management of hyperleukocytosis in an adult patient with acute lymphoblastic leukemia and ataxia-telangiectasia

Keklik M., Sivgin S., Kalin B. S., Akyol G., Pala C., Solmaz M., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.48, sa.3, ss.293-295, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

129. Successful treatment of gastric relapse in multiple myeloma with bortezomib after autologous hematopoietic stem cell transplantation (autoHSCT)

Sivgin S., Baldane S., KAYNAR L., Kurnaz F., BAŞKOL M., KULA M., et al.
Mediterranean Journal of Hematology and Infectious Diseases , cilt.5, sa.1, 2013 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

130. Analysis of lymphoid subgroups and immunoglobulin levels in patients with graft versus host disease after allogeneic haematopoietic stem cell transplantation

ÜNAL A., uzer e., KÖKER M. Y., yiğit h., ŞIVGIN S., KAYNAR L., et al.
Bone Marrow Transplantation , cilt.48, ss.532, 2013 (SCI-Expanded, Scopus) Creative Commons License identifier

131. A rare but severe complication of G CSF in healthy donor splenic rupture

AKYOL G., pala ç., EKİNCİ A., demir k., DÖRTDUDAK S., KAYNAR L., et al.
Bone Marrow Transplantation , cilt.48, ss.101, 2013 (SCI-Expanded, Scopus) identifier

132. Diagnosis of Aspergillus niger Peritonitis in a Peritoneal Dialysis Patient by Peritoneal Galactomannan and beta-D-Glucan Detection

Ates O., Metan G., Dundar T., Kiziltepe M., KOÇYİĞİT İ., ÜNAL A., et al.
PERITONEAL DIALYSIS INTERNATIONAL , cilt.33, sa.2, ss.216-218, 2013 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

133. Pretransplant iron overload may be associated with increased risk of invasive fungal pneumonia (IFP) in patients that underwent allogeneic hematopoietic stem cell transplantation (alloHSCT)

Sivgin S., Baldane S., KAYNAR L., Kurnaz F., Pala C., Sivgin H., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.48, sa.1, ss.103-108, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

134. An Acute Transverse Myelitis Attack after Total Body Irradiation A Rare Case

Keklik M., KAYNAR L., YiILDIRIM A., ŞIVGIN S., EROĞLU C., CinGÖZ Ş., et al.
Case Reports in Hematology , cilt.2013, ss.1-4, 2013 (ESCI) Creative Commons License

135. Factors That Affect Survival in Patients with Allogeneic Hematopoetic Stem Cell Transplantation

Şahin C., KAYNAR L., KURNAZ F., PALA ÖZTÜRK Ç., ŞIVGIN S., ESER B., et al.
Erciyes Tıp Dergisi , cilt.34, sa.4, ss.178-83, 2012 (TRDizin)

136. P 21 THE COMPARISON OF GRANULOCYTE COLONY STIMULATING FACTORS FOR MOBILISATION IN PATIENTS WHO UNDERWENT AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION AUTOHSCT A SINGLE CENTER EXPERIENCE

ŞIVGIN S., KARAKUŞ E., KAYNAR L., KURNAZ F., PALA Ç., KEKLİK M., et al.
Transfusion And Apheresis Science , cilt.47, ss.31, 2012 (SCI-Expanded, Scopus)

137. LIPID APHAERESIS TREATMENT IN TWIN PREGNANT PATIENT WITH FAMILIAL HYPERCHOLESTEROLEMIA

Pala Ç., Keklik M., Şıvgın S., Akyol G., Kaynar L., Solmaz M., et al.
Transfusion And Apheresis Science , cilt.47, ss.39-40, 2012 (SCI-Expanded, Scopus)

138. P 43 THE CONTROL OF ACUTE LYMPHOBLASTIC LEUKAEMIA CAUSED HYPERLEUKOCYTOSIS WITH LEUKOPHERESIS ON AN ADULT ATAXIA TELANGIECTASIA PATIENT

KEKLİK M., ŞIVGIN S., KALIN B. S., AKYOL G., PALA Ç., SOLMAZ M., et al.
Transfusion And Apheresis Science , cilt.47, ss.41, 2012 (SCI-Expanded, Scopus)

139. P 41 TREATMENT OF HYPERBILIRUBINEMIA WITH PLASMA EXCHANGE IN ERCIYES UNIVERSITY

KEKLİK M., ŞIVGIN S., PALA Ç., SOLMAZ M., KAYNAR L., ÇETİN M., et al.
Transfusion And Apheresis Science , cilt.47, ss.40-41, 2012 (SCI-Expanded, Scopus)

140. Plerixafor use in patients with previous mobilization failure: A multicenter experience

Tekgunduz E., Altuntas F., Sivgin S., Aki S. Z., DÖNMEZ A., Topcuoglu P., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.47, sa.1, ss.77-80, 2012 (SCI-Expanded, Scopus) identifier identifier identifier

141. ınvestigation of presence of cytomegalovirus DNA by real time polymerase chain reaction in patients underwent transplantation

İnci M., GÖKAHMETOĞLU S., ÇETİN M., OYMAK O., ÜNAL A.
Journal of new world sciences academy , cilt.7, ss.7-11, 2012 (Hakemli Dergi)

142. Efficacy and safety of oral deferasirox treatment in the posttransplant period for patients who have undergone allogeneic hematopoietic stem cell transplantation (alloHSCT)

Sivgin S., ESER B., Bahçebaşı S., KAYNAR L., kurnaz F., Uzer E., et al.
ANNALS OF HEMATOLOGY , cilt.91, sa.5, ss.743-749, 2012 (SCI-Expanded, Scopus) identifier identifier identifier

143. Flow cytometry method as a diagnostic tool for pleural fluid involvement in a patient with multiple myeloma.

Keklik M., Sivgin S., Pala C., Eroglu C., Akyol G., Kaynar L., et al.
Mediterranean journal of hematology and infectious diseases , cilt.4, 2012 (SCI-Expanded, Scopus) identifier identifier

144. Predictive Value of Pretransplant Serum Lactate Dehydrogenase (LDH) Levels for Survival in Patients who have undergone Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT)

ŞIVGIN S., ÖzenmiŞ T., KAYNAR L., KURNAZ F., ŞIVGIN H., BALDANE S., et al.
Journal of Stem Cell Research Therapy , cilt.2, sa.1, ss.1-6, 2012 (Hakemli Dergi) Creative Commons License

145. Pretransplant serum ferritin level may be a predictive marker for outcomes in patients having undergone allogeneic hematopoietic stem cell transplantation

ŞIVGIN S., BALDANE S., KAYNAR L., KURNAZ F., PALA Ç., Sivgin H., et al.
NEOPLASMA , cilt.59, sa.2, ss.183-190, 2012 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

146. Factors that affect survival in patients with allogeneic hematopoetic stem cell transplantation Allojenik hematopoetik kök hücre nakli yapılan hastalarda saǧkalım üzerine etkisi olan faktörlerin deǧerlendirilmesi

ŞAHİN C., KAYNAR L., KURNAZ F., PaLA C., ŞIVGIN S., ESER B., et al.
Erciyes Tip Dergisi , cilt.34, sa.4, ss.178-183, 2012 (Scopus, TRDizin) Creative Commons License identifier

147. Rituximab in Combination with Bendamustine or Chlorambucil for Treating Patients with Chronic Lymphocytic Leukemia: Interim Results of a Phase IIIb Study (MaBLe)

İLHAN O., ÜNAL A.
Blood , cilt.120, ss.2744, 2012 (SCI-Expanded, Scopus)

148. Exome sequencing reveals germline NPAT mutation as a candidate risk factor for Hodgkin lymphoma

Saarinen S., Aavikko M., Aittomaki K., Launonen V., Lehtonen R., Franssila K., et al.
BLOOD , cilt.118, sa.3, ss.493-498, 2011 (SCI-Expanded, Scopus) identifier identifier identifier

149. No improvement of survival with reduced- versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patients

Thiel U., Wawer A., Wolf P., Badoglio M., Santucci A., Klingebiel T., et al.
ANNALS OF ONCOLOGY , cilt.22, sa.7, ss.1614-1621, 2011 (SCI-Expanded, Scopus) identifier identifier identifier

150. Are university students a favorable target group for blood donation campaigns?

ESER B., Kurnaz F., KAYNAR L., Yay M., Sivgin S., ÜNAL A., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.27, sa.4, ss.275-281, 2010 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier

151. Malignancies Diagnosed During Pregnancy and Treated With Chemotherapy or Other Modalities (Review of 27 Cases) Multicenter Experiences

Ustaalioglu B. B. O., Gumus M., ÜNAL A., Cayir K., Sever O., Bilici A., et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , cilt.20, sa.5, ss.698-703, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

152. Primary brain T-cell lymphoma concomitant with CNS tuberculosis in a kidney transplant patient

SİPAHİOĞLU M. H., ALTUNTAŞ F., AYBAL A., ÜNAL A., KAYNAR L., KONTAŞ O., et al.
ERCİYES TIP DERGİSİ , cilt.31, sa.3, ss.256-260, 2009 (TRDizin) Sürdürülebilir Kalkınma

153. Effects of Imatinib Mesylate on Renin-Angiotensin System (RAS) Activity During the Clinical Course of Chronic Myeloid Leukaemia

Sayitoglu M., Haznedaroglu I. C., Hatirnaz O., Erbilgin Y., AKSU S., Koca E., et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH , cilt.37, sa.4, ss.1018-1028, 2009 (SCI-Expanded, Scopus) identifier

154. Primary Brain T cell Lymphoma Concomitant with CNS Tuberculosis in a Kidney Transplant Patient

SİPAHİOĞLU M. H., ALTUNTAŞ F., AYBAL A., ÜNAL A., KAYNAR L., KONTAŞ O., et al.
Erciyes Tıp Dergisi , cilt.31, ss.256-260, 2009 (Scopus, TRDizin) Sürdürülebilir Kalkınma identifier

155. Higher prevalence of toxoplasmosis in victims of traffic accidents suggest increased risk of traffic accident in Toxoplasma-infected inhabitants of Istanbul and its suburbs

Kocazeybek B., Oner Y. A., Turksoy R., Babur C., Cakan H., Sahip N., et al.
FORENSIC SCIENCE INTERNATIONAL , cilt.187, ss.103-108, 2009 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

156. Ga 67 Tutulumu Diffüz Büyük Hücreli Lenfoma Hastalarında Tedavi Sonrası Aktif Rezidüel Hastalık ve Klinik Sonucun Belirleyicisi

SARI H. I., KULA M., ESER B., KAYNAR L., ALTUNTAŞ F., TUTUŞ A., et al.
Erciyes Tıp Dergisi , cilt.30, ss.8-13, 2008 (TRDizin)

157. A multicenter retrospective study defining the clinical and hematological manifestations of brucellosis and pancytopenia in a large series: Hematological malignancies, the unusual cause of pancytopenia in patients with brucellosis

Sari I., Altuntas F., Hacioglu S., KOÇYİĞİT I., Sevinc A., Sacar S., et al.
AMERICAN JOURNAL OF HEMATOLOGY , cilt.83, sa.4, ss.334-339, 2008 (SCI-Expanded, Scopus) identifier identifier identifier

158. Therapeutic plasma exchange in patients with neurologic diseases: Retrospective multicenter study

KAYNAR L., Altuntas F., Aydogdu I., Turgut B., KOÇYİĞİT I., Hacioglu S. K., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.38, sa.2, ss.109-115, 2008 (SCI-Expanded, Scopus) identifier

159. Ga-67 uptake: A predictor of post-therapy active residual disease and clinical outcome in patients with diffuse large cell lymphoma

Sari I., KULA M., ESER B., KAYNAR L., Altuntaş F., KOÇYİĞİT I., et al.
Erciyes Tip Dergisi , cilt.30, sa.1, ss.8-13, 2008 (ESCI, Scopus, TRDizin) identifier identifier

160. Comparison of Plateletpheresis on the Fenwal Amicus and Fresenius Com.Tec Cell Separators

Altuntas F., Sari I., KOÇYİĞİT I., KAYNAR L., Hacioglu S., ÖZTÜRK A., et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY , cilt.35, sa.5, ss.368-373, 2008 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

161. Active immunotherapy for cancer patients using tumor lysate pulsed dendritic cell vaccine: A safety study

Ovali E., Dikmen T., SÖNMEZ M., Yilmaz M., ÜNAL A., Dalbasti T., et al.
Journal of Experimental and Clinical Cancer Research , cilt.26, sa.2, ss.209-214, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

162. The effect of budesonide mouthwash on oral chronic graft versus host disease

Sari I., Altuntas F., Kocyigit I., Sisman Y., Eser B., Unal A., et al.
AMERICAN JOURNAL OF HEMATOLOGY , cilt.82, sa.5, ss.349-356, 2007 (SCI-Expanded, Scopus) identifier identifier identifier

163. Comparison of the Fenwal Amicus and Fresenius Com.Tec cell separators for autologous peripheral blood progenitor cell collection

Altuntas F., Kocyigit I., Ozturk A., Kaynar L., Sari I., Oztekin M., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.36, sa.2, ss.159-167, 2007 (SCI-Expanded, Scopus) identifier

164. Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: A retrospective multicenter study

Altuntaş F., Aydoğdu I., Kabukcu S., Kocyigit I., Çıkım K., Sarı I., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.36, sa.1, ss.57-67, 2007 (SCI-Expanded, Scopus) identifier identifier identifier

165. Horner's Syndrome Secondary to Internal Jugular Catheterization: A Case Report

Sari I., Aybal A., Eser B., Unal A., ALTUNTAŞ F., ÜNAL A., et al.
ERCIYES MEDICAL JOURNAL , cilt.28, sa.4, ss.230-232, 2006 (ESCI, Scopus, TRDizin) identifier identifier

166. Juguler santral venöz kateterizasyona bağlı Horner sendromu: Bir olgu sunumu

SARI H. I., AYBAL A., ESER B., ÜNAL A., ALTUNTAŞ F., ÜNAL A., et al.
ERCİYES TIP DERGİSİ , cilt.28, sa.4, ss.230-232, 2006 (TRDizin)

167. Acute lymphoblastic leukemia associated with brucellosis in two patients with fever and pancytopenia

ESER B., ALTUNTAŞ F., SOYUER S., ER Ö., CANÖZ Ö., COŞKUN H. Ş., et al.
YONSEI MEDICAL JOURNAL , cilt.31, sa.47, ss.741-4, 2006 (SCI-Expanded, Scopus)

168. Comparison of different conditioning regimens used in relapse agressive non Hodgkin lymphoma ICE CNV beam

ÜNAL A., SARI H. İ., KAYNAR L., ALTUNTAŞ F., ESER B., ÖZKAN M., et al.
Annals Of Oncology , cilt.17, ss.201, 2006 (SCI-Expanded, Scopus)

169. Primary cutaneous lymphomas: A retrospective evaluation Pri̇mer kutanöz lenfoma: Retrospekti̇f deǧerlendi̇ rme

Ferahbaş A., Ulaş Y., Utaş S., Eser B., CANÖZ Ö., Sari I., et al.
Erciyes Tip Dergisi , cilt.28, sa.2, ss.77-81, 2006 (Scopus, TRDizin) identifier

170. Primary Cutaneous Lymphomas: A Retrospective Evaluation

Ferahbas A., Ulas Y., Utas S., Eser B., Canoz O., Sari I., et al.
ERCIYES MEDICAL JOURNAL , cilt.28, sa.2, ss.77-81, 2006 (ESCI, Scopus, TRDizin) identifier identifier

171. Primer kutanöz lenfoma: retrospektif değerlendirme

FERAHBAŞ A., ÇETİN M., ULAŞ Y., UTAŞ S., ESER B., CANÖZ Ö., et al.
ERCİYES TIP DERGİSİ , cilt.28, sa.2, ss.77-81, 2006 (TRDizin)

172. Prognostic significance of Fas (CD95/APO-1) positivity in patients with primary nodal diffuse large B-cell lymphoma

Eser B., Sarı İ., Canoz Z., Altuntaş F., çakmak E., Ozturk A., et al.
AMERICAN JOURNAL OF HEMATOLOGY , cilt.81, sa.5, ss.307-314, 2006 (SCI-Expanded, Scopus) identifier identifier identifier

173. Clinicopathologic characteristics and therapeutic outcomes of primary gastrointestinal non-Hodgkin's lymphomas in central Anatolia, in Turkey

Eser B., Kaplan B., Unal A., Canoz Z., ALTUNTAŞ F., Sari H. I., et al.
YONSEI MEDICAL JOURNAL , cilt.47, sa.1, ss.22-33, 2006 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

174. Kikuchi-Fujimoto disease: A rare but important cause of fever and lymphadenopathy in pregnant women

Altuntas F., Sari I., Canoz Z., Yildiz O., Eser B., Cetin M., et al.
AMERICAN JOURNAL OF HEMATOLOGY , cilt.81, sa.2, ss.118-120, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

175. Microbiologically documented infections following peripheral blood stem cell transplantation: Single center experience

Altuntaş F., YILDIZ O., Eser B., Alp E., Sari I., ÇETİN M., et al.
Turkish Journal of Haematology , cilt.22, sa.3, ss.133-145, 2005 (SCI-Expanded, Scopus) identifier identifier

176. Familial nodular lymphocyte predominant Hodgkin lymphoma: Successful treatment with CHOP plus rituximab

Unal A., SARI İ., Deniz K., Ozkan M., Kontas O., Eser B., et al.
LEUKEMIA & LYMPHOMA , cilt.46, sa.11, ss.1613-1617, 2005 (SCI-Expanded, Scopus) identifier identifier identifier

177. Intravenous gamma globulin is effective as an urgent treatment in Brucella-induced severe thrombocytopenic purpura

ALTUNTAŞ F., Yildiz O., SARI İ., Eser B., Cetin M., Unal A.
AMERICAN JOURNAL OF HEMATOLOGY , cilt.80, sa.3, ss.204-206, 2005 (SCI-Expanded, Scopus) identifier identifier identifier

178. Overexpression of cyclooxygenase-2 in multiple myeloma: Association with reduced survival

Cetin M., BUYUKBERBER S., DEMIR M., SARI İ., SARI İ., Deniz K., et al.
AMERICAN JOURNAL OF HEMATOLOGY , cilt.80, sa.3, ss.169-173, 2005 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

179. The role of plasma exchange in HELLP syndrome

Eser B., Guven M., Unal A., Coskun R., Altuntas F., Sungur M., et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.11, sa.2, ss.211-217, 2005 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

180. Familial nodular lymphocyte predominant Hodgkin lymphoma: Successful treatment with CHOP plus rituximab

Ünal A.
JOURNAL OF LEUKEMIA AND LYMPHOMA , cilt.46, sa.11, ss.1613-1617, 2005 (SCI-Expanded)

181. Severe thrombotic microangiopathy associated with brucellosis: Successful treatment with plasmapheresis

ALTUNTAŞ F., Eser B., SARI İ., Yildiz O., Cetin M., Unal A.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.11, sa.1, ss.105-108, 2005 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

182. Effect of increasing doses of aspirin on platelet function as measured by PFA-100 in patients with diabetes

Abaci A., Yilmaz Y., Caliskan M., Bayram F., Cetin M., Unal A., et al.
THROMBOSIS RESEARCH , cilt.116, sa.6, ss.465-470, 2005 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

183. A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer.

Altinbas M., Coskun H. Ş., Er O., Ozkan M., Eser B., Unal A., et al.
Journal of thrombosis and haemostasis : JTH , cilt.2, sa.8, ss.1266-71, 2004 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

184. Fludarabine based chemotherapy in chronic lymphocytic leukemia/lymphoma Kronik lenfositik lösemi/lenfoma'da fludarabin tabanli kemoterapi

Altuntaş F., Eser B., CANÖZ Ö., Er Ö., ÖZKAN M., Şivgin S., et al.
THOD - Turk Hematoloji-Onkoloji Dergisi , cilt.14, sa.2, ss.80-85, 2004 (Scopus, TRDizin) identifier

185. Intravenous catheter infections in patient with hematological malignancy Hematoloji̇k mali̇gni̇teli̇ hastalarda i̇ntravenöz kateter i̇nfeksi̇yonlari

Altuntaş F., YILDIZ O., ÜNAL A.
Erciyes Tip Dergisi , cilt.26, sa.1, ss.25-32, 2004 (SCI-Expanded, Scopus, TRDizin) identifier

186. Meropenem +/- granulocyte colony stimulating factor in the treatment of febrile neutropenic patients with cancer: Prospective randomized study

Er O., Coskun H. Ş., Altinbas M., Ozkan M., Eser B., Cetin M., et al.
JOURNAL OF CHEMOTHERAPY , cilt.16, sa.3, ss.288-292, 2004 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

187. The significance of P53 and Bcl-2 protein expression in patients with primary gastrointestinal diffuse large B-cell lymphomas

Cakmak E., Eser B., Sari I., Altuntas F., CANÖZ Ö., ÖZKAN M., et al.
ANNALS OF ONCOLOGY , cilt.15, ss.162, 2004 (SCI-Expanded, Scopus) identifier

188. Ga-67 uptake: A predictor of active minimaly residual disease and clinical outcome in patients with diffuse large cell lymphoma

ÜNAL A., Sari I., Eser B., KULA M., Altuntas F., ÇETİN M.
ANNALS OF ONCOLOGY , cilt.15, ss.161, 2004 (SCI-Expanded, Scopus) identifier

189. The results of Erciyes University in the treatment of advanced stage colorectal cancer İleri̇ evre kolorektal kanserleri̇n teda vi̇si̇nde Erci̇yes Üni̇versi̇tesi̇ sonuçlari

ER Ö., Coşkun H. Ş., ALTINBAŞ M., ÖZKAN M., ESER B., Çetin M., et al.
Erciyes Tip Dergisi , cilt.25, sa.3, ss.144-149, 2003 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma identifier

190. •HODGKİN HASTALIĞINDA İLK BASAMAK TEDAVİ SONUÇLARI:TEK MERKEZ DENEYİMİ

Altuntaş F., Eser B., Kaplan B., Canöz Ö., GÜNDOĞAN K., Özkan M., et al.
Uluslararası Hematoloji-Onkoloji Dergisi , cilt.13, sa.2, ss.79-86, 2003 (Scopus, TRDizin)

191. Pulmonary and chest wall involvement in multiple myeloma Multipl Miyelomada Akciger ve Gögüs Duvari Tutulumu.

Oymak F. S., KARAMAN A., SOYUER I., KARAMAN H., GÜLMEZ İ., DEMİR R., et al.
Tüberküloz ve toraks , cilt.51, sa.1, ss.27-32, 2003 (SCI-Expanded, Scopus, TRDizin) identifier identifier

192. Palliative chemotherapy in patients with locally advanced gastric cancer Lokal i̇leri̇ evre mi̇de kanseri̇nde palyati̇f kemoterapi̇

Coşkun H. Ş., ER Ö., TANRIVERDİ F., ALTINBAŞ M., ESER B., ÜNAL A., et al.
Erciyes Tip Dergisi , cilt.25, sa.1, ss.16-20, 2003 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma identifier

193. High prevalence of diabetes in patients with pancreatic cancer in central

ÇETİN M., BAYRAM F., ALTINBAŞ M., ÜNAL A., KELEŞTEMUR H. F.
DIABETES RESEARCH AND CLINICAL PRACTICE , cilt.58, sa.2002, ss.97-100, 2002 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

194. Subclavian vein obstruction: A rare complication in malignant mesothelioma Subklavyen ven tikanikliǧi: Mali̇gn mezotelyomada nadi̇r bi̇r kompli̇kasyon

Coşkun H. Ş., Er Ö., Altinbaş M., Eser B., Özcan N., ÇETİN M., et al.
Erciyes Tip Dergisi , cilt.24, sa.3, ss.144-148, 2002 (Scopus, TRDizin) identifier

195. Kanserli hastalarda gelişen febril nötropeni ataklarında ampirik meropenem monoterapisinin değerlendirilmesi

ER Ö., ÇETİN M., COŞKUN H. Ş., ALTINBAŞ M., ESER B., ÜNAL A.
ANKEM , ss.18-21, 2002 (Hakemli Dergi) Sürdürülebilir Kalkınma

196. Early stage Hodgkin's disease: Experiences of erciyes university Erken evre Hodgkin hastaliǧi: Erciyes üni̇versi̇tesi̇ deneyi̇mi̇

Coşkun H., Er Ö., Eser B., ÇETİN M., Altinbaş M., Soyuer S., et al.
Erciyes Tip Dergisi , cilt.24, sa.3, ss.120-125, 2002 (Scopus, TRDizin) identifier

197. Metastatik meme kanserinde vinorelbin ve doksorubisin kemoterapisinin etkinliği

Coşkun H. Ş., Altınbaş M., Er Ö., Eser B., Keklik M., Çetin M., et al.
Türkiye Tıp Dergisi Dahili Tıp Bilimleri , cilt.8, sa.1, ss.13-17, 2001 (TRDizin) Sürdürülebilir Kalkınma

198. Allogeneic peripheral blood stem cell transplantation in a patient with acute myelocytic leukemia: First experience of Erciyes University

ÜNAL A., ÇETİN M., Eser B., PATIROĞLU T., Altinbaş M., Karahacioǧlu E., et al.
Erciyes Tip Dergisi , cilt.22, sa.4, ss.197-200, 2000 (Scopus, TRDizin) identifier

199. Autologous peripheral blood stem cell transplantation in patients with resistant and/or relapsing lmphoma: analysis of the single center results

ÜNAL A., ÇETİN M., Eser B.
Blood , cilt.96, 2000 (SCI-Expanded, Scopus) identifier identifier

200. Empirical treatment approach in febrile neutropenic patients Ateşli̇ nötropeni̇k hastada ampi̇ri̇k tedavi̇ yaklaşimi

Eser B., ÇETİN M., ÜNAL A., Coşkun H., Kayabaş Ü., Altinbaş M.
Erciyes Tip Dergisi , cilt.22, sa.3, ss.155-162, 2000 (Scopus, TRDizin) identifier

201. Kanserli hastalarda bakteremi ve fungemi ile birlikteliği olan faktörler

ESER B., ÇETİN M., ÜNAL A., COŞKUN H. Ş., KAYABAŞ Ü., ALTINBAŞ M.
FLORA , cilt.5, sa.1, ss.49-55, 2000 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

202. Akut myelositer lösemili bir hastada allojenik periferik kök hücre transplantasyonu: Erciyes üniversitesi ilk deneyimi

ÜNAL A., ÇETİN M., ESER B., PATIROĞLU T., ALTINBAŞ M., KARAHACIOĞLU E., et al.
ERCİYES TIP DERGİSİ , cilt.22, sa.4, ss.197-200, 2000 (TRDizin)

203. Fluorourasil bazlı rejimlere dirençli metastatik kolorektal kanserli hastalarda irinotekan kullanımı

ER Ö., COŞKUN H. Ş., ÇETİN M., ESER B., ÜNAL A.
Kanser Gündemi , cilt.5, sa.3, ss.59-60, 2000 (Hakemli Dergi) Sürdürülebilir Kalkınma

204. Ateşli nötropenik hastada ampirik tedavi yaklaşımı

ESER B., ÇETİN M., ÜNAL A., COŞKUN H. Ş., ALTINBAŞ M.
ERCİYES TIP DERGİSİ , cilt.22, sa.3, ss.155-162, 2000 (TRDizin)

205. Activated protein c resistance in Turkish women with pre-eclampsia

ÜNAL A., ÇETİN M., ESER B., TAYYAR M., ER Ö., COŞKUN H. Ş.
The Hematology Journal , cilt.1, sa.1, 2000 (SCI-Expanded) Sürdürülebilir Kalkınma

206. Efficacy of vinorelbine and doxorubicin combination chemoterapy in metastaic breast cancer

ER Ö., ALTINBAŞ M., ESER B., KEKLİK M., ÇETİN M., KARAHACIOĞLU E., et al.
European İnstitute of Oncology , 2000 (SCI-Expanded) Sürdürülebilir Kalkınma

207. Hodgkin disease: result of single center in central anatolia of Turkey

COŞKUN H. Ş., ESER B., ÇETİN M., ÜNAL A., ALTINBAŞ M., ER Ö., et al.
American Society of Clinical Oncology , cilt.19, 2000 (SCI-Expanded)

208. Soliter intrakraniyal plazmasitom

COŞKUN H. Ş., KONTAŞ O., ALTINBAŞ M., ER Ö., KARAHACIOĞLU E., ESER B., et al.
Türkiye Tıp Dergisi , cilt.7, sa.4, ss.195-199, 2000 (Hakemli Dergi)

209. Non frozen autologous peripheral blood stem cell transplantation in relapsing and resistant lymphoma

ÜNAL A., ÇETİN M., PATIROĞLU T., ESER B., ALTINBAŞ M.
BONE MARROW TRANSPLANTATION , cilt.25, sa.1, 2000 (SCI-Expanded, Scopus)

210. Efficiency of cyclophosphamide, epirubicin, vincristine (CEV) /- low molecular weight heparin (LMWH) in small cell lung cancer (SCLC): Preliminary results.

ÖZKAN M., ESER B., ÜNAL A., ÇETİN M.
Annals Of Oncology , cilt.11, ss.117, 2000 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

211. Hepatocellular carcinoma: Results of Erciyes University Medical School Hepatoseluler karsinom: Erciyes Universitesi Tip Fakultesi Sonuclari

Altinbas M., ÇETİN M., Canbulat M., Eser B., Komitoglu H., Guven M., et al.
Erciyes Tip Dergisi , cilt.22, sa.1, ss.35-43, 2000 (Scopus, TRDizin) identifier

212. hepatoselüler kansinom: erciyes tıp sonuçları

ALTINBAŞ M., ÇETİN M., CANBULAT M. A., ESER B., GÜVEN M., ÜNAL A.
ERCİYES TIP DERGİSİ , cilt.22, sa.1, ss.35-43, 2000 (TRDizin)

213. Effects of DMSO on P Selectin expression during storage of platelet concentrates

Cetin M., Unal A., Eser B., Patiroglu T., Arslan O., Er O., et al.
Blood , cilt.96, 2000 (SCI-Expanded, Scopus) identifier

214. Small cell carcinoma of the pancreas Pankreasin kucuk hucreli kanseri

Altinbas M., ÇETİN M., Karahacioglu E., Komitoglu H., ÜNAL A., Alper M.
Erciyes Tip Dergisi , cilt.21, sa.2, ss.126-129, 1999 (Scopus, TRDizin) Sürdürülebilir Kalkınma identifier

215. Multiple myeloma: Results of Erciyes University Medical Faculty Multipl myelom: Erciyes Universitesi Tip Fakultesi Sonuclari

Altinbas M., ÇETİN M., Karahacioglu E., KAPLAN B., ÜNAL A.
Erciyes Tip Dergisi , cilt.21, sa.2, ss.117-120, 1999 (Scopus, TRDizin) identifier

216. Pericardial invasion by diffuse malignant pleural mesothelioma causing ST segment elevation ST segment yukselmesi ile seyreden diffuz malign plevral mezotelyomanin perikard invazyonu

Çetin M., Eser B., Ünal A., Er O., Kula M., Oztork O., et al.
Erciyes Tip Dergisi , cilt.21, sa.4, ss.229-234, 1999 (Scopus, TRDizin) identifier

217. Islet cell tumor Adacik hucreli tumor

Altinbas M., Karahacioglu E., ÇETİN M., Arar M., Canbulat A., ÜNAL A., et al.
Erciyes Tip Dergisi , cilt.21, sa.4, ss.225-228, 1999 (Scopus, TRDizin) identifier

218. Low dose idarubicine, vincristin, prednisone and g-csf plus atra for the treatmant of poor risk myelodysplastic syndrome

ÜNAL A., ÇETİN M., ESER B., COŞKUN H. Ş.
Journal of the american society of hematology , cilt.94, sa.10, 1999 (SCI-Expanded)

219. ST segment yükselmesi ile seyreden diffüz malign plevral mezotelyomanın perikard invazyonu

ÇETİN M., ESER B., ÜNAL A., ER Ö., KULA M., ÖZTÜRK Ö., et al.
ERCİYES TIP DERGİSİ , cilt.21, sa.4, ss.229-234, 1999 (TRDizin)

220. Adacık hücreli tümör

ALTINBAŞ M., KARAHACIOĞLU E., ÇETİN M., ARAR M., CANBULAT M. A., ÜNAL A., et al.
ERCİYES TIP DERGİSİ , cilt.21, sa.4, ss.225-228, 1999 (TRDizin)

221. Febril nötropenik kanserli hastalarda hematopoietik büyüme faktörlerinin kullanımı

ÇETİN M., ESER B., ÜNAL A., GÜVEN M., ALTINBAŞ M.
Türk Hematoloji-Onkoloji Dergisi , cilt.9, sa.3, ss.166-171, 1999 (TRDizin) Sürdürülebilir Kalkınma

222. Pankreas küçük hücreli kanser

ALTINBAŞ M., ÇETİN M., KARAHACIOĞLU E., ÜNAL A., ALPER M.
ERCİYES TIP DERGİSİ , cilt.21, sa.2, ss.126-129, 1999 (TRDizin) Sürdürülebilir Kalkınma

223. Multipl Myelom: Erciyes üniversitesi tıp fakültesi sonuçları

ALTINBAŞ M., ÇETİN M., KARAHACIOĞLU E., KAPLAN B., ÜNAL A.
ERCİYES TIP DERGİSİ , cilt.21, sa.2, ss.117-120, 1999 (TRDizin)

224. Oral demir tedavisinde ferro sulfat ve ferrik polimaltozun etkinliğinin karşılaştırılması

ÇETİN M., ESER B., GÜVEN M., ÜNAL A., ALTINBAŞ M.
Türk Hematoloji-Onkoloji Dergisi , cilt.9, sa.2, ss.96-100, 1999 (TRDizin)

225. Frequency of flutamide induced hepatotoxicity in patients with prostate carcinoma

Cetin M., Demirci D., Unal A., Altinbas M., Guven M., Unluhizarci K.
HUMAN & EXPERIMENTAL TOXICOLOGY , cilt.18, sa.3, ss.137-140, 1999 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

226. Investigation of hepatitis E virus antibodies in sera obtained from hemodialysis patients and healthy donors

Kılıç H., Oymak O., Ünal A., Şahin İ.
Erciyes Tıp Dergisi , cilt.21, sa.2, ss.80-82, 1999 (Scopus, TRDizin) Sürdürülebilir Kalkınma identifier

227. Bir kür kemoterapi ile tam cevap sağlanan anaplastik büyük hücreli lenfoma (Ki-1) vakası

ALTINBAŞ M., PATIROĞLU T. E., ÇETİN M., CANBULAT M. A., ÜNAL A.
Türkiye Tıp Dergisi , cilt.6, sa.3, ss.177-180, 1999 (Hakemli Dergi)

228. Investigation of Hepatitis E virus Antibodies in hemodialysis patients and donor sera

KILIÇ H., Utaş C., OYMAK O., ÜNAL A., Karagöz S., Şahin İ.
Erciyes Tıp Derg , ss.180-182, 1999 (Hakemli Dergi) Sürdürülebilir Kalkınma

229. Küçük hücreli akciğer kanseri: erciyes üniversitesi tıp fakültesi sonuçları

ALTINBAŞ M., KARAHACIOĞLU E., GÖKTAŞ Z., ÇETİN M., GÜVEN M., ÜNAL A., et al.
Klinik Bilimler , cilt.4, sa.6, ss.826-829, 1998 (Hakemli Dergi) Sürdürülebilir Kalkınma

230. Geç lokal nüks gösteren meme kanseri

ALTINBAŞ M., ESER B., GÖKTAŞ Z., ÇETİN M., KARAHACIOĞLU E., ALPER M., et al.
Türk Hematoloji-Onkoloji Dergisi , cilt.8, sa.3, ss.165-168, 1998 (TRDizin) Sürdürülebilir Kalkınma

231. Shedding of the nails due to chemotherapy (onychomadesis)

Cetin M., Utas S., Unal A., Aitmbas M.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY , cilt.11, sa.2, ss.193-194, 1998 (SCI-Expanded, Scopus) identifier identifier identifier

232. Malign melanomda atipik klinik davranış

ALTINBAŞ M., GÖKTAŞ Z., ÇETİN M., ÜNAL A., ALPER M.
Türk Hematoloji-Onkoloji Dergisi , cilt.8, sa.4, ss.234-237, 1998 (TRDizin)

233. Multicentric granulocytic sarkom of the breast with acute myelogenous leukemia

GÜRSOY Ş., GÜVEN K., ÇETİN M., ÜNAL A., ÖZTÜRK F., ÖZCAN N.
Turkish Journal of Cancer , cilt.28, sa.2, ss.84-87, 1998 (SCI-Expanded, TRDizin)

234. İleri evre küçük hücreli akciğer kanserinde tedavi sonuçlarımız

KARAHACIOĞLU E., ALTINBAŞ M., ÜNAL A., KAPLAN B., YILDIZ O. G., GÜLMEZ İ., et al.
Türkiye Tıp Dergisi , cilt.5, sa.1, ss.22-25, 1998 (Hakemli Dergi) Sürdürülebilir Kalkınma

235. Multicentric granulocytic sarcoma of the breast with acute myelogenous leukemia

GÜRSOY Ş., GÜVEN K., ÇETİN M., ÜNAL A., ÖZTÜRK F., Ozcan N.
Turkish Journal of Cancer , cilt.28, sa.2, ss.84-87, 1998 (Scopus, TRDizin) identifier

236. Aktive protein-c rezistansına bağlı ailevi trombofili

OYMAK F. S., ÜNAL A., ÇETİN M., GÜLMEZ İ., DEMİR R., ÖZESMİ M.
ERCİYES TIP DERGİSİ , cilt.20, sa.1, ss.70-74, 1998 (TRDizin)

237. Mediastinal nonhodgkin lenfomaya bağlı bilateral periferik fasiyal paralizi.

Yiğitbaşı G., ÜNLÜ Y., Yavaşoğlu H., Soysal V., ÜNAL A.
Türk Hematoloji-Onkoloji Dergisi , ss.41-42, 1997 (Hakemli Dergi)

238. The relationship between plazma lipid parameters, fibrinogen and lipid peroxidation in patients with angina pectoris and acute myocardial infarction

Köse S. K., Doğan P., Çetin M., Ünal A.
Turk j med sic , cilt.27, sa.1, ss.435-439, 1997 (Hakemli Dergi)

239. Kanserli hastalarda hiperkalsemi

GÜVEN M., ALTINBAŞ M., BAYRAM F., ÇETİN M., ÜNAL A.
Optimal Tıp Dergisi , cilt.10, sa.2, ss.43-46, 1997 (Hakemli Dergi) Sürdürülebilir Kalkınma

240. Farklı gruplarda HCV ve seroprevalansı

KILIÇ H., Utaş C., ÜNAL A., Arınç H., Yıldırım M., Şahin İ.
Viral Hepatit Derg , ss.73-75, 1997 (Hakemli Dergi)

241. Metastatik meme kanserli hastalarda vinorelbine - adriamycin ve cyclophosphamid - adriamycin - 5 fluorouracil (CAF) kemoterapisi sonuçları

ALTINBAŞ M., KARAHACIOĞLU E., GÜVEN M., KAPLAN B., ÇETİN M., ÜNAL A.
ACTA ONCOLOGİCA TURCİCA , cilt.29, ss.116-119, 1996 (TRDizin) Sürdürülebilir Kalkınma

242. 2000'li yıllarda onkolojinin görünümü

ALTINBAŞ M., ÇETİN M., ÜNAL A.
ERCİYES TIP DERGİSİ , cilt.18, sa.1, ss.68-70, 1996 (TRDizin)

243. 22q+ varyant ph1 kromozomlu bir kronik miyeloid lösemi olgusu.

Ceylaner S., CÜCER N., ÜNAL A., Özyazgan I., SAATÇİ Ç., ÖZKUL Y.
Erciyes Üniversitesi Sağlık Bilimleri Dergisi , cilt.4, ss.42-45, 1995 (Hakemli Dergi)

244. İleri evre over kanseri tedavisinde kombine kemoterapi uygulamaları

MÜDERRİS İ. İ., ÜNAL A., KARAHACIOĞLU E., ÇETİN M., ALTINBAŞ M.
ERCİYES TIP DERGİSİ , cilt.17, sa.3, ss.271-274, 1995 (TRDizin) Sürdürülebilir Kalkınma

245. Bronkoalveolar karsinomlu bir olguda Isospora belli

Kılıç H., Sümerkan B., Koç A. N., Ünal A., Sehmen E.
Mikrobiyoloji Bulteni , ss.410-413, 1995 (SCI-Expanded, Scopus, TRDizin)

246. Kanserli Hastalarda HBsAg ve Anti HCV pozitifliği

ÜNAL A., Özmerdivenli R., KILIÇ H., Karahacıoğlu E.
TÜRK ONKOLOJİ DERGİSİ , sa.10, ss.106, 1995 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

247. Kemoterapi alan hastalara yan etkilere yönelik eğitim verilmesi

TAŞÇI S., ÜNAL A., ÜSTÜNBAŞ H. B.
ERCİYES TIP DERGİSİ , cilt.16, sa.1, 1994 (Scopus, TRDizin)

248. Romatoid faktör ve antinükleer antikoru seropozitif olan hasta serumlarında ELISA ve SF denreyleri

KILIÇ H., ÜSTÜNBAŞ H. B., ÜNAL A., ALTINDAŞ K., ŞAHİN I.
TÜRKİYE PARAZİTOLOJİ DERGİSİ , ss.29-34, 1991 (Scopus, TRDizin)

249. Relations among diabetic polyneuropathy,HbA1c,albuminuria and duration of disease in non-insulin dependent diabetes mellitus.

Keleştimur F., MİRZA M., Ünal A., Özbakır Ö., Soyuer A., Başer E., et al.
Erciyes Tıp Dergisi , cilt.12, ss.230-336, 1990 (Scopus, TRDizin) Sürdürülebilir Kalkınma

250. Asymptomatic bacteriuria in patients with diabetes mellitus Diabetes mellitus'lu hastalarda asemptomatik bakteriüri.

Keleştimur F., ÜNAL A., Paşaoglu H., Başar E., KILIÇ H., DOĞANAY M.
Mikrobiyoloji bülteni , cilt.24, sa.2, ss.126-132, 1990 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

251. Diabetes mellituslu hastalarda asemptomatik bakteriemi.

Keleştemur H. F., Ünal A., Paşaoğlu H., Kılıç H., Başer E.
Mikrobiyoloji Bulteni , cilt.2, sa.1, ss.126-132, 1990 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 41

1. Lenfoplazmasitik İnfiltrasyon ile Karakterize IGG4 İlişkili Sistemik Amiloidoz: Nadir Bir Olgu Sunumu

EMRE ÜNSAL Ş., YILDIRIM KARAHANCI M., ASLANER H. A., YÜKSEL T. S., MANDACI ŞANLI N., AKYOL G., et al.
11. DENEYSEL HEMATOLOJİ KONGRESİ, Gaziantep, Türkiye, 29 - 31 Ağustos 2025, (Tam Metin Bildiri)

2. Primer Refrakter Lenfomada Globitamab'ın Etkinliği

KEKLİK M., AKYOL G., MANDACI ŞANLI N., ÜNAL A.
11. DENEYSEL HEMATOLOJİ KONGRESİ, Gaziantep, Türkiye, 29 - 31 Ağustos 2025, (Özet Bildiri)

3. Duodenum Foliküler Lenfomada Bekle-Gör Yaklaşımı

YÜKSEL T. S., AKYOL G., MANDACI ŞANLI N., KONTAŞ O., CAN SEZGİN G., ÜNAL A.
11. DENEYSEL HEMATOLOJİ KONGRESİ, Gaziantep, Türkiye, 29 - 31 Ağustos 2025, (Özet Bildiri)

4. MARJİNAL ZON LENFOMA TANISI İLE TAKİPLİ HASTALARIN KLİNİK SONUÇLARININ DEĞERLENDİRİLMESİ

EMRE ÜNSAL Ş., MANDACI ŞANLI N., ÜNAL A.
5. LÖSEMİ LENFOMA MİYELOM KONGRESİ, Ankara, Türkiye, 22 - 24 Mayıs 2025, (Özet Bildiri)

5. Kronik Lenfositer Lösemi Hastalarında Görülen Genetik Mutasyonların Sıklığı ve Surveye Etkisi

GÖLBAŞI M., ÜNAL A., ÖZKUL Y., DÜNDAR M., MANDACI ŞANLI N., AKYOL G., et al.
7. HEMATOLOJIK NADIR HASTALIKLAR KONGRESI, Girne, Kıbrıs (Kktc), 22 - 25 Şubat 2025, (Özet Bildiri)

6. Lepra Hastalığını Taklit Eden Granülositik Sarkom Vakası

TAŞER KANAT N., EMRE ÜNSAL Ş., MANDACI ŞANLI N., ÜNAL A.
7. HEMATOLOJIK NADIR HASTALIKLAR KONGRESI, Girne, Kıbrıs (Kktc), 22 - 25 Şubat 2025, (Özet Bildiri)

7. Multipl Miyelom hastasında;Otolog Kök Hücre Nakli sonrası, idamelenalidomid sürecinde gelişen ALL tedavisi ve ikinci OKHN deneyimi:İlginç bir Vaka.

ÇUKADAR N., FİDAN K., TAŞER KANAT N., EMRE ÜNSAL Ş., YILDIRIM KARAHANCI M., MANDACI ŞANLI N., et al.
7. HEMATOLOJIK NADIR HASTALIKLAR KONGRESI, Girne, Kıbrıs (Kktc), 22 - 25 Şubat 2025, (Özet Bildiri)

8. Yetişkin Yaşta Nüks Medulloblastom Vakasında Otolog Kök Hücre Nakli Deneyimi: Vaka Raporu

FİDAN K., İPEKÇİ E. S., TAŞER KANAT N., UYSAL Ş. E., YILDIRIM KARAHANCI M., MANDACI ŞANLI N., et al.
7. HEMATOLOJIK NADIR HASTALIKLAR KONGRESI, Girne, Kıbrıs (Kktc), 22 - 25 Şubat 2025, (Özet Bildiri)

9. MANAGEMENT OF BLEEDING IN A PATIENT WITH ACQUIRED HAEMOPHILIA A: A CASE REPORT

YILDIRIM KARAHANCI M., KEKLİK M., EMRE ÜNSAL Ş., TAŞER KANAT N., ASLANER H. A., AKYOL G., et al.
XV Eurasian Hematology-Oncology Congress, İstanbul, Türkiye, 28 Nisan 2024 - 30 Nisan 2025, cilt.46, ss.22-23, (Özet Bildiri) identifier

10. RICHTER TRANSFORMATION OF CLL DISEASE: A CASE REPORT WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT

MEMMEDOVA E., MANDACI ŞANLI N., ÜNAL A.
18. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 21 - 24 Kasım 2024, cilt.46, ss.25, (Özet Bildiri) identifier

11. A CASE OF LIFE-THREATENING ACQUIRED COAGULOPATHY IN CONTRAST TO HYPERVISCOSITY: LYMPHOPLASMACYTIC LYMPHOMA

MANDACI ŞANLI N., YILDIRIM KARAHANCI M., BOYRAZ Ö., ÜNAL A.
11th Aegean Hematology Oncology Symposium, KOS, Yunanistan, 19 - 22 Eylül 2024, (Özet Bildiri)

12. Çok Nadir Fakat Ölümcül Bir Yan Etki: İbrutinib İlişkili Fulminan Karaciğer Yetmezliği

MANDACI ŞANLI N., ÜNAL A.
8. Hematolojik İmmünoloji Kongresi, İzmir, Türkiye, 5 - 07 Eylül 2024, (Özet Bildiri)

13. Chronic Lymphocytic Leukemia: Immune Dysregulation and Management: A Case Report

FİDAN K., MANDACI ŞANLI N., AKYOL G., KEKLİK M., ÜNAL A.
11th SOHO Türkiye Meeting, İstanbul, Türkiye, 28 - 30 Nisan 2024, cilt.24, ss.348, (Özet Bildiri) identifier identifier

14. Vitality and Engraftment Times in Allogeneic Hematopoietic Stem Cell Transplantations Made With Frozen and Fresh Product

FİDAN K., BAYSAL S., MANDACI ŞANLI N., AKYOL G., KEKLİK M., ÜNAL A.
11th SOHO Türkiye Meeting, İstanbul, Türkiye, 28 - 30 Nisan 2024, cilt.24, ss.593, (Özet Bildiri) identifier identifier

15. Frequency of Genetic Mutations in Patients With Chronic Lymphocytic Leukemia and Their Effects on Survival

GÖLBAŞI M., ÜNAL A., ÖZKUL Y., DÜNDAR M., MANDACI ŞANLI N., AKYOL G., et al.
11th SOHO Türkiye Meeting, İstanbul, Türkiye, 28 - 30 Nisan 2024, cilt.24, ss.345, (Özet Bildiri) identifier identifier

16. Treatment of Hematopoietic Stem Cell Transplant-Associated Microangiopathy with Eculizumab

AKYOL G., EMRE ÜNSAL Ş., MANDACI ŞANLI N., KEKLİK M., ÜNAL A.
11th SOHO Türkiye Meeting, İstanbul, Türkiye, 28 - 30 Nisan 2024, cilt.24, ss.594, (Özet Bildiri) identifier identifier

17. Rare Anti-M Alloantibody Positivity in a Pregnant Woman and the Effectiveness of Plasmapheresis in Treatment: A Case Report

FİDAN K., BAYSAL S., KAYNAR L., YAY M., MANDACI ŞANLI N., AKYOL G., et al.
11th SOHO Türkiye Meeting, İstanbul, Türkiye, 28 Nisan 2024, cilt.24, ss.423, (Özet Bildiri) identifier identifier

18. Diagnosis and Treatment of Primary Hepatic Lymphoma: Case Report

MEMMEDOVA E., GÖKALP E. Ş., MANDACI ŞANLI N., ÜNAL A.
11th SOHO Türkiye Meeting, İstanbul, Türkiye, 28 - 30 Nisan 2024, cilt.24, ss.471-472, (Özet Bildiri) identifier identifier

19. GENE RESISTANCE IN CHRONIC MYELOID LEUKEMIA

OKTEN EKIZ H., TAN B., KEKLİK M., ÜNAL A., MANDACI ŞANLI N., ÖZKUL Y.
X. Uluslararası Katılımlı Deneysel Hematoloji Kongresi, Gaziantep, Türkiye, 30 Ağustos 2024, (Özet Bildiri)

20. HEMATOLOJİK MALİGNİTELİ HASTALARDA GRANÜLOSİT TRANSFÜZYONU NÖTROPENİDEN ÇIKIŞI HIZLANDIRIYOR

ÇELİK A., ÜNAL A., BAYDAR M., KEKLİK M., MANDACI ŞANLI N., AKYOL G.
12. EGE HEMATOLOJİ ONKOLOJİ KONGRESİ, İzmir, Türkiye, 14 - 16 Mart 2024, (Özet Bildiri)

21. TWO CASES OF B-ALL IN MYELOMA PATIENTS RECEIVING LONG MAINTENANCE IMID THERAPY AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION

AKYOL G., BAYDAR M., FİDAN K., TAŞER KANAT N., MANDACI ŞANLI N., KEKLİK M., et al.
49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, Online Kongre, Türkiye, 23 - 26 Nisan 2023, cilt.58, ss.494, (Özet Bildiri)

22. SUCCESSFUL TREATMENT WITH GRANULOCYTE TRANSFUSION AND EARLY NEUTROPHIL ENGRAFTMENT IN ALLOGENEIC TRANSPLANT PATIENTS WITH FEBRILE NEUTROPENIA; DOES GRANULOCYTE TRANSFUSION SHORTEN THE NEUTROPHIL ENGRAFTMENT TIME?

ÜNAL A., TUBAY Ş. E., KEKLİK M., MANDACI ŞANLI N., AKYOL G.
49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, Online Kongre, Türkiye, 23 - 26 Nisan 2023, cilt.58, ss.382-383, (Özet Bildiri)

23. IBRUTINIB RELATED NEUROPATHY: A CASE REPORT

GÜVEN Z. T., TAŞER KANAT N., MANDACI ŞANLI N., ÜNAL A.
XIV Eurasian Hematology Oncology Congress, İstanbul, Türkiye, 11 - 14 Ekim 2023, cilt.45, ss.33, (Özet Bildiri) identifier

24. ACUTE PROMYELOCYTIC LEUKEMIA AND STEM CELL TRANSPLANTATION: CASE SERIES, SINGLE CENTER EXPERIENCE

FİDAN K., BAYDAR M., TAŞER KANAT N., MANDACI ŞANLI N., KEKLİK M., ÜNAL A.
10th SOHO Türkiye Meeting-Society of Hematologic Oncology 2023 Annual Meeting, İstanbul, Türkiye, 5 - 07 Mayıs 2023, cilt.23, ss.271, (Özet Bildiri) identifier identifier

25. Gastrointestinal Hemoraji Gelişen Lenfoma Hastasında Tedavi Yönetimi: Zor Bir Vaka

TAŞER KANAT N., MANDACI ŞANLI N., ÜNAL A.
9. Karadeniz Hematoloji Kongresi, Samsun, Türkiye, 16 - 17 Haziran 2023, (Özet Bildiri)

26. AML HASTALARINDA YDAC KONSOLİDASYON KEMOTERAPİSİNİN 1.2.3. GÜNLERDE VE 1.3.5. GÜNLERDE VERİLMESİNİN KIYASLANMASI

YAVUZ M. S., MANDACI ŞANLI N., TUBAY Ş. E., ÜNAL A.
3. LÖSEMİ LENFOMA MİYELOM KONGRESİ, Ankara, Türkiye, 25 - 27 Mayıs 2023, (Özet Bildiri)

27. FAKTÖR VII EKSİKLİĞİNDE CERRAHİ:TEK MERKEZ DENEYİMİ,VAKA SERİSİ

FİDAN K., BAYDAR M., TAŞER KANAT N., AKYOL G., MANDACI ŞANLI N., KEKLİK M., et al.
9. Hemofili Vakalarla Eğitim Sempozyumu, Antalya, Türkiye, 7 - 09 Nisan 2023, (Özet Bildiri)

28. HEMATOPOETİK KÖK HÜCRE NAKLİ SIRASINDA GELİŞEN EPİLEPTİK NÖBETLERİN DEĞERLENDİRİLMESİ: TEK MERKEZ DENEYİMİ

YILMAZ B. N., ÇELİK S., TUBAY Ş. E., MANDACI ŞANLI N., ÜNAL A.
11. Ege Hematoloji Onkoloji Kongresi, İzmir, Türkiye, 16 - 18 Mart 2023, (Özet Bildiri)

29. Nüks Hodgkin Lenfoma Tanılı Hastada Brentixumab Vedotin+AVD Sonrası Gelişen Akut Miyokardiyal İnfarktüs:Olgu Sunumu

AKYOL G., FİDAN K., MANDACI ŞANLI N., BAYDAR M., TAŞER KANAT N., KEKLİK M., et al.
Hematoloji Uzmanlık Derneği 16. Ulusal Kongresi, Mersin, Türkiye, 18 - 20 Kasım 2022, (Özet Bildiri)

30. Kronik Lenfositik Lösemide Sekonder İmmun Yetmezlik: Hastalık İlişkili Mi? Yoksa Tedavi İlişkili Mi?

FİDAN K., MANDACI ŞANLI N., BAYDAR M., TAŞER KANAT N., AKYOL G., KEKLİK M., et al.
9. Hematolojik Onkoloji Kongresi, İstanbul, Türkiye, 17 - 19 Kasım 2022, (Özet Bildiri)

31. Secondary hypogammaglobulinemia in cll

ÜNAL A., FİDAN K., KEKLİK M., ÇELİK S., BAYDAR M., MANDACI ŞANLI N., et al.
48th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Dubrovnik, Hırvatistan, 19 - 23 Mart 2022, cilt.57, ss.306-307, (Özet Bildiri)

32. Long-term outcome in patients receiving imatinib for steroid-refractory chronic GVHD/for refractory chronic graft-versushost disease with fibrotic features: A single-center experience

MANDACI ŞANLI N., KARAKUŞ F., ÜNAL A., KEKLİK M.
48th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Dubrovnik, Hırvatistan, 19 - 23 Mart 2022, cilt.57, ss.212-213, (Özet Bildiri)

33. Long-term follow-up of ruxolitinib for therapy in corticosteroid refractory chronic graft-versus-host disease: A single center-experience

MANDACI ŞANLI N., KARAKUŞ F., KEKLİK M., ÜNAL A.
48th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Dubrovnik, Hırvatistan, 19 - 23 Mart 2022, cilt.57, ss.205, (Özet Bildiri)

34. İNTRAKRANİYAL KANAMA İLE BAŞVURAN HAFİF HEMOFİLİ A VAKASI:OLGU SUNUMU

FİDAN K., BAYDAR M., ÇELİK S., TAŞER KANAT N., AKYOL G., MANDACI ŞANLI N., et al.
8. Hemofili Vakalarla Eğitim Sempozyumu, Antalya, Türkiye, 18 - 20 Şubat 2022, (Özet Bildiri)

35. NAKİL ÖNCESİ YÜKSEK SERUM D-DİMER DÜZEYİ ALLOJENİK HEMATOPOİETİK KÖK HÜCRE NAKLİ YAPILAN HASTALARDA SAĞKALIMI BELİRLEMEDE PROGNOSTİK BİR BELİRTEÇ OLABİLİR

MANDACI ŞANLI N., EMEKLİOĞLU M., KEKLİK M., ÜNAL A.
VII.Uluslararası Katılımlı Deneysel Hematoloji Kongresi, Online Kongre, Türkiye, 3 - 05 Eylül 2021, (Özet Bildiri)

36. Immune trombocytic purpura during the course of COVID‐19 disease:three cases report 

FİDAN K., ÜNAL A., KEKLİK M., AKYOL G., BAYDAR M., ÇELİK S., et al.
6 th European Congress of  Immunology, Online Kongre, Türkiye, 1 - 04 Eylül 2021, cilt.51, ss.329, (Tam Metin Bildiri) identifier identifier identifier

37. Comparison of the Efficiency of High and Low Dose Cyclophosphamide for Stem Cell Mobilization

BİREKUL A., ÜNAL A., ÜNAL M. Ç., ERMİŞ TURAK E., AKYOL G., MANDACI ŞANLI N., et al.
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015, cilt.50, ss.5562-5563, (Özet Bildiri)

38. Multiple case LAD1/variant syndrome family from Turkey, diagnosed by screening tests

Metin A., Kizilates S., Koker M. Y., Hogg N.
13th European-Soc-for-Immunodeficiencies/10th Int-Patient-Org-for-Primary-Immunodeficiencies/8th Int-Nursing-Group-for-Immunodeficiencies Meeting, Hertogenbosch, Hollanda, 16 - 19 Ekim 2008, cilt.154, ss.185, (Özet Bildiri) identifier

39. Two omenn syndrome patients with one novel homozygous RAG2 mutations from Turkey

Metin A., Kose G., Arhan E., Cuhaci B., Koker M. Y., Villa A.
13th European-Soc-for-Immunodeficiencies/10th Int-Patient-Org-for-Primary-Immunodeficiencies/8th Int-Nursing-Group-for-Immunodeficiencies Meeting, Hertogenbosch, Hollanda, 16 - 19 Ekim 2008, cilt.154, ss.185, (Özet Bildiri) identifier

40. Clinical and laboratory spectrum of 55 common variable immunodeficiency patients

Metin A., Koeker Y. M., Keskin K., Saribacak E.
13th European-Soc-for-Immunodeficiencies/10th Int-Patient-Org-for-Primary-Immunodeficiencies/8th Int-Nursing-Group-for-Immunodeficiencies Meeting, Hertogenbosch, Hollanda, 16 - 19 Ekim 2008, cilt.154, ss.80, (Özet Bildiri) identifier

41. Clinical improvement of epidermodysplasia verruciformis lesions treated with rh-peg interferon-beta in Hyper-IgE syndrome

Metin A., Han U., Koker Y. M.
13th European-Soc-for-Immunodeficiencies/10th Int-Patient-Org-for-Primary-Immunodeficiencies/8th Int-Nursing-Group-for-Immunodeficiencies Meeting, Hertogenbosch, Hollanda, 16 - 19 Ekim 2008, cilt.154, ss.60-61, (Özet Bildiri) identifier
Kitaplar 1

1. Yetişkin Tip Kök Hücreler ve Güncel Klinik Uygulamaları: Hematopoetik Kök Hücre ve Mezenkimal Kök Hücre

MANDACI ŞANLI N., ÜNAL A.
ÇOCUK NÖROLOJISI PRATIĞINDE KÖK HÜCRE MULTIDISIPLINER YAKLAŞIM, CANPOLAT MEHMET, Editör, Akademisyen Yayınevi, Ankara, ss.63-81, 2023
Metrikler

Yayın

534

Yayın (WoS)

252

Yayın (Scopus)

198

Atıf (WoS)

2599

H-İndeks (WoS)

23

Atıf (Scopus)

3129

H-İndeks (Scopus)

24

Atıf (Scholar)

627

H-İndeks (Scholar)

15

Atıf (TrDizin)

1

H-İndeks (TrDizin)

1

Atıf (Diğer Toplam)

2

Proje

18

Tez Danışmanlığı

2

Açık Erişim

47
BM Sürdürülebilir Kalkınma Amaçları